CN102083783A - 取代的联苯gpr40调节剂 - Google Patents
取代的联苯gpr40调节剂 Download PDFInfo
- Publication number
- CN102083783A CN102083783A CN2008801199462A CN200880119946A CN102083783A CN 102083783 A CN102083783 A CN 102083783A CN 2008801199462 A CN2008801199462 A CN 2008801199462A CN 200880119946 A CN200880119946 A CN 200880119946A CN 102083783 A CN102083783 A CN 102083783A
- Authority
- CN
- China
- Prior art keywords
- alkyl
- compound
- alkenyl
- formula
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 IC1*CCCC1 Chemical compound IC1*CCCC1 0.000 description 30
- VFZOBGXUPKMJLY-FVOPLDGLSA-N CC/C=C/[C@H](CC(OC)=O)c1cc(O)ccc1 Chemical compound CC/C=C/[C@H](CC(OC)=O)c1cc(O)ccc1 VFZOBGXUPKMJLY-FVOPLDGLSA-N 0.000 description 3
- YAGQTKVZMWEMLI-QMMMGPOBSA-N C[C@@H](CC(OC)=O)c1cc(O)ccc1 Chemical compound C[C@@H](CC(OC)=O)c1cc(O)ccc1 YAGQTKVZMWEMLI-QMMMGPOBSA-N 0.000 description 3
- NPNVFCMSTAQRTA-UHFFFAOYSA-N CC(C)(C)c(cc(cc1)C(OC)=O)c1OS(C(F)(F)F)(=O)=O Chemical compound CC(C)(C)c(cc(cc1)C(OC)=O)c1OS(C(F)(F)F)(=O)=O NPNVFCMSTAQRTA-UHFFFAOYSA-N 0.000 description 2
- BWAJPJAKHMTOBO-UHFFFAOYSA-N CC(C)(CCC1)C1c1cc(CCl)ccc1-c1cc(C(F)F)ccc1F Chemical compound CC(C)(CCC1)C1c1cc(CCl)ccc1-c1cc(C(F)F)ccc1F BWAJPJAKHMTOBO-UHFFFAOYSA-N 0.000 description 2
- NDPATDDQIMRIBS-SHQCIBLASA-N CC(C)(CCC1)[C@H]1c(cc(COc1cccc([C@H](CC(OC)=O)C2CC2)c1F)cc1)c1-c1cc(OC)ncc1F Chemical compound CC(C)(CCC1)[C@H]1c(cc(COc1cccc([C@H](CC(OC)=O)C2CC2)c1F)cc1)c1-c1cc(OC)ncc1F NDPATDDQIMRIBS-SHQCIBLASA-N 0.000 description 2
- HNJWHUWIWYQTKO-UHFFFAOYSA-N CC1(C)C(c(cc(C(OC)=O)c(F)c2)c2OS(C(F)(F)F)(=O)=O)=CCC1 Chemical compound CC1(C)C(c(cc(C(OC)=O)c(F)c2)c2OS(C(F)(F)F)(=O)=O)=CCC1 HNJWHUWIWYQTKO-UHFFFAOYSA-N 0.000 description 2
- ZDBVOAJBLIHEAJ-UHFFFAOYSA-N CCC(C(C(OC(C)(C)O1)=O)C1=O)c(cccc1OC)c1F Chemical compound CCC(C(C(OC(C)(C)O1)=O)C1=O)c(cccc1OC)c1F ZDBVOAJBLIHEAJ-UHFFFAOYSA-N 0.000 description 2
- NXQRLWOYSXKJJB-SECBINFHSA-N COC(C[C@@H](C=C)c1cc(O)ccc1)=O Chemical compound COC(C[C@@H](C=C)c1cc(O)ccc1)=O NXQRLWOYSXKJJB-SECBINFHSA-N 0.000 description 2
- HUXPCBCILWAAMR-SNVBAGLBSA-N COC(C[C@@H](CC=C)c1cc(O)ccc1)=O Chemical compound COC(C[C@@H](CC=C)c1cc(O)ccc1)=O HUXPCBCILWAAMR-SNVBAGLBSA-N 0.000 description 2
- DYNGMOSTHNWWAT-SNVBAGLBSA-N COC(C[C@H](C1CC1)c(cccc1O)c1F)=O Chemical compound COC(C[C@H](C1CC1)c(cccc1O)c1F)=O DYNGMOSTHNWWAT-SNVBAGLBSA-N 0.000 description 2
- PUTQBYLORMXXFS-SECBINFHSA-N COC(C[C@H](c1cccc(O)c1)N)=O Chemical compound COC(C[C@H](c1cccc(O)c1)N)=O PUTQBYLORMXXFS-SECBINFHSA-N 0.000 description 2
- FYMSCQVWXDGTLT-UHFFFAOYSA-N COC(c(cc(CO)cc1)c1-c(cc(cc1)F)c1F)=O Chemical compound COC(c(cc(CO)cc1)c1-c(cc(cc1)F)c1F)=O FYMSCQVWXDGTLT-UHFFFAOYSA-N 0.000 description 2
- OJXDXCJWQWSVEX-SDNWHVSQSA-N C/C(/c1cc(OCc2ccccc2)ccc1)=C\C(OC)=O Chemical compound C/C(/c1cc(OCc2ccccc2)ccc1)=C\C(OC)=O OJXDXCJWQWSVEX-SDNWHVSQSA-N 0.000 description 1
- OXEIQCURDSIXDE-UHFFFAOYSA-N C=CCC(CC(O)=O)c1cc(O)ccc1 Chemical compound C=CCC(CC(O)=O)c1cc(O)ccc1 OXEIQCURDSIXDE-UHFFFAOYSA-N 0.000 description 1
- ZQRKEPLCWXLCBB-BBQAJUCSSA-N CC#C[C@@H](CC(O)=O)C(CC1)=CC=C1OCc1cc(C2=CCC(C(F)(F)F)C=C2)ccc1 Chemical compound CC#C[C@@H](CC(O)=O)C(CC1)=CC=C1OCc1cc(C2=CCC(C(F)(F)F)C=C2)ccc1 ZQRKEPLCWXLCBB-BBQAJUCSSA-N 0.000 description 1
- ZLXQCHWSHHSMFW-UHFFFAOYSA-N CC(C(C)(C)C)c(cc(COc1cccc(C(CC(OC)=O)C2CC2)c1)cc1)c1-c1cc(OC)ccc1F Chemical compound CC(C(C)(C)C)c(cc(COc1cccc(C(CC(OC)=O)C2CC2)c1)cc1)c1-c1cc(OC)ccc1F ZLXQCHWSHHSMFW-UHFFFAOYSA-N 0.000 description 1
- LJGAWNGSYWTIGE-UHFFFAOYSA-N CC(C)(C(c(cc(cc1)O)c1-c1cc(OC)ccc1N)OC)C=C Chemical compound CC(C)(C(c(cc(cc1)O)c1-c1cc(OC)ccc1N)OC)C=C LJGAWNGSYWTIGE-UHFFFAOYSA-N 0.000 description 1
- SQZQAKLNMNGLIR-UHFFFAOYSA-N CC(C)(C)C(c(cc(cc1)C(OC)=O)c1OC1OCCCC1)=C Chemical compound CC(C)(C)C(c(cc(cc1)C(OC)=O)c1OC1OCCCC1)=C SQZQAKLNMNGLIR-UHFFFAOYSA-N 0.000 description 1
- AFUWQGLCXYKREA-UHFFFAOYSA-N CC(C)(C)C(c1cc(CO)ccc1-c(cc(cc1)F)c1F)=O Chemical compound CC(C)(C)C(c1cc(CO)ccc1-c(cc(cc1)F)c1F)=O AFUWQGLCXYKREA-UHFFFAOYSA-N 0.000 description 1
- ANONBNZDWTZSLS-HHHXNRCGSA-N CC(C)(C)Cc(cc(COc1cc([C@@H](CC(OC)=O)O)ccc1)cc1)c1-c1cc(OC)ccc1F Chemical compound CC(C)(C)Cc(cc(COc1cc([C@@H](CC(OC)=O)O)ccc1)cc1)c1-c1cc(OC)ccc1F ANONBNZDWTZSLS-HHHXNRCGSA-N 0.000 description 1
- BADOMHMQUQSKRJ-MUUNZHRXSA-N CC(C)(C)Cc(cc(COc1cccc([C@H](CC(OC)=O)C2CC2)c1)cc1)c1-c1cc(OC)ccc1F Chemical compound CC(C)(C)Cc(cc(COc1cccc([C@H](CC(OC)=O)C2CC2)c1)cc1)c1-c1cc(OC)ccc1F BADOMHMQUQSKRJ-MUUNZHRXSA-N 0.000 description 1
- FXRJDFOVKGAGAD-HXUWFJFHSA-N CC(C)(C)[C@@H](c(cc(CCl)cc1)c1-c1ccccc1F)OCCOC Chemical compound CC(C)(C)[C@@H](c(cc(CCl)cc1)c1-c1ccccc1F)OCCOC FXRJDFOVKGAGAD-HXUWFJFHSA-N 0.000 description 1
- DQCOHBUDQNYWDM-SMSORMJASA-N CC(C)(C)[C@@H](c(cc(COc(cccc1[C@@H](CC(O)=O)C2CC2)c1F)cc1)c1-c1cc(OC)ncc1F)OC Chemical compound CC(C)(C)[C@@H](c(cc(COc(cccc1[C@@H](CC(O)=O)C2CC2)c1F)cc1)c1-c1cc(OC)ncc1F)OC DQCOHBUDQNYWDM-SMSORMJASA-N 0.000 description 1
- DQCOHBUDQNYWDM-YKGWIAGDSA-N CC(C)(C)[C@@H](c(cc(COc1cccc([C@H](CC(O)=O)C2CC2)c1F)cc1)c1-c1cc(OC)ncc1F)OC Chemical compound CC(C)(C)[C@@H](c(cc(COc1cccc([C@H](CC(O)=O)C2CC2)c1F)cc1)c1-c1cc(OC)ncc1F)OC DQCOHBUDQNYWDM-YKGWIAGDSA-N 0.000 description 1
- FIDPMURUXWPVEO-QGZVFWFLSA-N CC(C)(C)[C@@H](c1cc(CCl)ccc1-c1cc(OC)ncc1F)O Chemical compound CC(C)(C)[C@@H](c1cc(CCl)ccc1-c1cc(OC)ncc1F)O FIDPMURUXWPVEO-QGZVFWFLSA-N 0.000 description 1
- RUPDWUNWYUWGQQ-QPIRBTGLSA-N CC(C)(C)[C@@H](c1cc(CCl)ccc1C(C(C)(C=C1)F)C=C1OC)O Chemical compound CC(C)(C)[C@@H](c1cc(CCl)ccc1C(C(C)(C=C1)F)C=C1OC)O RUPDWUNWYUWGQQ-QPIRBTGLSA-N 0.000 description 1
- AMJJJGIBHDKSSP-ZJFPTPTDSA-N CC(C)(C)[C@H](C(CC(CCl)C=C1)=C1c1cc(OC)ncc1F)OC Chemical compound CC(C)(C)[C@H](C(CC(CCl)C=C1)=C1c1cc(OC)ncc1F)OC AMJJJGIBHDKSSP-ZJFPTPTDSA-N 0.000 description 1
- FXRJDFOVKGAGAD-FQEVSTJZSA-N CC(C)(C)[C@H](c(cc(CCl)cc1)c1-c1ccccc1F)OCCOC Chemical compound CC(C)(C)[C@H](c(cc(CCl)cc1)c1-c1ccccc1F)OCCOC FXRJDFOVKGAGAD-FQEVSTJZSA-N 0.000 description 1
- DQCOHBUDQNYWDM-RCRUUEGKSA-N CC(C)(C)[C@H](c(cc(COc(cccc1[C@H](CC(O)=O)C2CC2)c1F)cc1)c1-c1cc(OC)ncc1F)OC Chemical compound CC(C)(C)[C@H](c(cc(COc(cccc1[C@H](CC(O)=O)C2CC2)c1F)cc1)c1-c1cc(OC)ncc1F)OC DQCOHBUDQNYWDM-RCRUUEGKSA-N 0.000 description 1
- FFAHNHWZXIMYFD-IBGZPJMESA-N CC(C)(C)[C@H](c1cc(CCl)ccc1-c1cc(OC)ccc1F)OC Chemical compound CC(C)(C)[C@H](c1cc(CCl)ccc1-c1cc(OC)ccc1F)OC FFAHNHWZXIMYFD-IBGZPJMESA-N 0.000 description 1
- HNWVKNWVQVPVGJ-UHFFFAOYSA-N CC(C)(C)[S+](C)OCc(cc1)cc(C2(CCCC2)O)c1-c1cc(OC)ccc1F Chemical compound CC(C)(C)[S+](C)OCc(cc1)cc(C2(CCCC2)O)c1-c1cc(OC)ccc1F HNWVKNWVQVPVGJ-UHFFFAOYSA-N 0.000 description 1
- DOZFTYFIVPNZRM-UHFFFAOYSA-N CC(C)(C)[Si](C)(C)OCc(cc1)cc(C(CC=C)(CC=C)O)c1-c1cc(OC)ccc1F Chemical compound CC(C)(C)[Si](C)(C)OCc(cc1)cc(C(CC=C)(CC=C)O)c1-c1cc(OC)ccc1F DOZFTYFIVPNZRM-UHFFFAOYSA-N 0.000 description 1
- NPQXZIBSQCYQFT-UHFFFAOYSA-N CC(C)(C)[Si](C)(C)OCc(cc1)cc(C2(CCCC2)O)c1-c(cc(cc1)OC)c1F Chemical compound CC(C)(C)[Si](C)(C)OCc(cc1)cc(C2(CCCC2)O)c1-c(cc(cc1)OC)c1F NPQXZIBSQCYQFT-UHFFFAOYSA-N 0.000 description 1
- CCNLDPGQDDNOFD-UHFFFAOYSA-N CC(C)(C)c(cc(CCl)cc1)c1-c(cc1)cnc1OC Chemical compound CC(C)(C)c(cc(CCl)cc1)c1-c(cc1)cnc1OC CCNLDPGQDDNOFD-UHFFFAOYSA-N 0.000 description 1
- MUOYPDBQLATAJX-UHFFFAOYSA-N CC(C)(C)c(cc(CCl)cc1)c1-c1cc(OC)ccc1F Chemical compound CC(C)(C)c(cc(CCl)cc1)c1-c1cc(OC)ccc1F MUOYPDBQLATAJX-UHFFFAOYSA-N 0.000 description 1
- WLGWZBORVODADD-UHFFFAOYSA-N CC(C)(C)c(cc(COc1cc(CCC(O)=O)ccc1)cc1)c1-c1cc(OC)ccc1 Chemical compound CC(C)(C)c(cc(COc1cc(CCC(O)=O)ccc1)cc1)c1-c1cc(OC)ccc1 WLGWZBORVODADD-UHFFFAOYSA-N 0.000 description 1
- CIMVOYUKPBDMPH-UHFFFAOYSA-N CC(C)(C)c(cc(COc1cc(CCC(OC)=O)ccn1)cc1)c1-c1cc(OC)ccc1F Chemical compound CC(C)(C)c(cc(COc1cc(CCC(OC)=O)ccn1)cc1)c1-c1cc(OC)ccc1F CIMVOYUKPBDMPH-UHFFFAOYSA-N 0.000 description 1
- HXCOUTIEIHEJCG-FQEVSTJZSA-N CC(C)(C)c(cc(COc1cccc([C@H](CC(O)=O)C=C)c1)cc1)c1-c(cc(cc1)OC)c1F Chemical compound CC(C)(C)c(cc(COc1cccc([C@H](CC(O)=O)C=C)c1)cc1)c1-c(cc(cc1)OC)c1F HXCOUTIEIHEJCG-FQEVSTJZSA-N 0.000 description 1
- HSVNSLSQJIZWBC-UHFFFAOYSA-N CC(C)(C)c1cc(C(OC)=O)ccc1-c1cc(OC2OCCCC2)ccc1F Chemical compound CC(C)(C)c1cc(C(OC)=O)ccc1-c1cc(OC2OCCCC2)ccc1F HSVNSLSQJIZWBC-UHFFFAOYSA-N 0.000 description 1
- BWYXOYTXSSFGNE-UHFFFAOYSA-N CC(C)(C)c1cc(CO)ccc1-c(cc(cc1)OC2OCCCC2)c1F Chemical compound CC(C)(C)c1cc(CO)ccc1-c(cc(cc1)OC2OCCCC2)c1F BWYXOYTXSSFGNE-UHFFFAOYSA-N 0.000 description 1
- ORRKBGKCRGLINN-QFIPXVFZSA-N CC(C)(C)c1cc(COc2cc([C@@H](CC=C)CC(O)=O)ccc2)ccc1-c1cc(OC)ccc1 Chemical compound CC(C)(C)c1cc(COc2cc([C@@H](CC=C)CC(O)=O)ccc2)ccc1-c1cc(OC)ccc1 ORRKBGKCRGLINN-QFIPXVFZSA-N 0.000 description 1
- ORRKBGKCRGLINN-JOCHJYFZSA-N CC(C)(C)c1cc(COc2cc([C@H](CC=C)CC(O)=O)ccc2)ccc1-c1cc(OC)ccc1 Chemical compound CC(C)(C)c1cc(COc2cc([C@H](CC=C)CC(O)=O)ccc2)ccc1-c1cc(OC)ccc1 ORRKBGKCRGLINN-JOCHJYFZSA-N 0.000 description 1
- XIZZRIDXRMEBCB-RUZDIDTESA-N CC(C)(C)c1cc(COc2cccc([C@@H](CC(O)=O)N)c2)ccc1-c1cc(OC)ccc1F Chemical compound CC(C)(C)c1cc(COc2cccc([C@@H](CC(O)=O)N)c2)ccc1-c1cc(OC)ccc1F XIZZRIDXRMEBCB-RUZDIDTESA-N 0.000 description 1
- IBVVTLHHIMSTSC-UHFFFAOYSA-N CC(C)(C)c1cc(COc2nccc(CCC(O)=O)c2)ccc1-c1cc(OC)ccc1F Chemical compound CC(C)(C)c1cc(COc2nccc(CCC(O)=O)c2)ccc1-c1cc(OC)ccc1F IBVVTLHHIMSTSC-UHFFFAOYSA-N 0.000 description 1
- DUYGBJCIDFWRCE-UHFFFAOYSA-N CC(C)(C1)CC(c2c-3ccc(C(OC)=O)c2)=CC1(C)[O](C)c(cc1)cc-3c1F Chemical compound CC(C)(C1)CC(c2c-3ccc(C(OC)=O)c2)=CC1(C)[O](C)c(cc1)cc-3c1F DUYGBJCIDFWRCE-UHFFFAOYSA-N 0.000 description 1
- GOLLEFLUKYPAOO-UHFFFAOYSA-N CC(C)(CC(C1)c2c-3ccc(C(OC)=O)c2)CC1(C)[O](C)c(cc1)cc-3c1F Chemical compound CC(C)(CC(C1)c2c-3ccc(C(OC)=O)c2)CC1(C)[O](C)c(cc1)cc-3c1F GOLLEFLUKYPAOO-UHFFFAOYSA-N 0.000 description 1
- IISZJGOERVJVIM-RXVAYIKUSA-N CC(C)(CCC1)C1c(cc(COc(cccc1[C@H](CC(OC)=O)C2CC2)c1F)cc1)c1-c1cc(C(F)F)ccc1F Chemical compound CC(C)(CCC1)C1c(cc(COc(cccc1[C@H](CC(OC)=O)C2CC2)c1F)cc1)c1-c1cc(C(F)F)ccc1F IISZJGOERVJVIM-RXVAYIKUSA-N 0.000 description 1
- XIFLHJQGNIWBAO-UHFFFAOYSA-N CC(C)(CCC1)C1c(cc(cc1)C(OC)=O)c1-c1cc(O)ccc1F Chemical compound CC(C)(CCC1)C1c(cc(cc1)C(OC)=O)c1-c1cc(O)ccc1F XIFLHJQGNIWBAO-UHFFFAOYSA-N 0.000 description 1
- KEBBLSNEPCCDRD-UHFFFAOYSA-N CC(C)(CCC1)C1c(cc(cc1)C(OC)=O)c1-c1cc(OCC(F)(F)F)ccc1F Chemical compound CC(C)(CCC1)C1c(cc(cc1)C(OC)=O)c1-c1cc(OCC(F)(F)F)ccc1F KEBBLSNEPCCDRD-UHFFFAOYSA-N 0.000 description 1
- JXYCIYHZFFHFQT-UHFFFAOYSA-N CC(C)(CCC1)C1c1cc(CO)ccc1-c1cc(C(F)F)ccc1F Chemical compound CC(C)(CCC1)C1c1cc(CO)ccc1-c1cc(C(F)F)ccc1F JXYCIYHZFFHFQT-UHFFFAOYSA-N 0.000 description 1
- LTKWTTPBFCEXJW-NSHDSACASA-N CC(C)(CCC1)[C@@H]1c(cc(C(OC)=O)c(F)c1)c1O Chemical compound CC(C)(CCC1)[C@@H]1c(cc(C(OC)=O)c(F)c1)c1O LTKWTTPBFCEXJW-NSHDSACASA-N 0.000 description 1
- YJIBAFSBFYQCFU-JFINJBMXSA-N CC(C)(CCC1)[C@@H]1c(cc(COc1cccc(C(CC(OC)=O)C2CC2)c1)cc1)c1-c1cc(OC)ccc1F Chemical compound CC(C)(CCC1)[C@@H]1c(cc(COc1cccc(C(CC(OC)=O)C2CC2)c1)cc1)c1-c1cc(OC)ccc1F YJIBAFSBFYQCFU-JFINJBMXSA-N 0.000 description 1
- SKLHRQXBCIIWPM-DEOSSOPVSA-N CC(C)(CCC1)[C@@H]1c(cc(COc1cccc(CCC(OC)=O)c1F)cc1)c1-c1cc(OC)ncc1F Chemical compound CC(C)(CCC1)[C@@H]1c(cc(COc1cccc(CCC(OC)=O)c1F)cc1)c1-c1cc(OC)ncc1F SKLHRQXBCIIWPM-DEOSSOPVSA-N 0.000 description 1
- BSSZAFUNAXXOJJ-LMSSTIIKSA-N CC(C)(CCC1)[C@@H]1c(cc(COc1cccc([C@@H](CC(C)=O)O)c1)cc1)c1-c1cc(C(F)F)ccc1F Chemical compound CC(C)(CCC1)[C@@H]1c(cc(COc1cccc([C@@H](CC(C)=O)O)c1)cc1)c1-c1cc(C(F)F)ccc1F BSSZAFUNAXXOJJ-LMSSTIIKSA-N 0.000 description 1
- WSACLGWLOUGJHE-AHKZPQOWSA-N CC(C)(CCC1)[C@@H]1c(cc(COc1cccc([C@@H](CC(O)=O)O)c1)cc1)c1-c1cc(C(F)F)ccc1F Chemical compound CC(C)(CCC1)[C@@H]1c(cc(COc1cccc([C@@H](CC(O)=O)O)c1)cc1)c1-c1cc(C(F)F)ccc1F WSACLGWLOUGJHE-AHKZPQOWSA-N 0.000 description 1
- PAMOFSHDYGFZLH-XZWHSSHBSA-N CC(C)(CCC1)[C@@H]1c(cc(COc1cccc([C@@H](CC(O)=O)O)c1)cc1)c1-c1cc(C2(C)OCCO2)ccc1 Chemical compound CC(C)(CCC1)[C@@H]1c(cc(COc1cccc([C@@H](CC(O)=O)O)c1)cc1)c1-c1cc(C2(C)OCCO2)ccc1 PAMOFSHDYGFZLH-XZWHSSHBSA-N 0.000 description 1
- DZNFAPNMPRGDBY-XTEPFMGCSA-N CC(C)(CCC1)[C@@H]1c(cc(COc1cccc([C@@H](CC(O)=O)O)c1)cc1)c1-c1cc(OC)ccc1F Chemical compound CC(C)(CCC1)[C@@H]1c(cc(COc1cccc([C@@H](CC(O)=O)O)c1)cc1)c1-c1cc(OC)ccc1F DZNFAPNMPRGDBY-XTEPFMGCSA-N 0.000 description 1
- WMVAFWMHOICRSH-LADGPHEKSA-N CC(C)(CCC1)[C@@H]1c(cc(COc1cccc([C@@H](CC(O)=O)O)c1F)cc1)c1-c1cc(OC)ncc1F Chemical compound CC(C)(CCC1)[C@@H]1c(cc(COc1cccc([C@@H](CC(O)=O)O)c1F)cc1)c1-c1cc(OC)ncc1F WMVAFWMHOICRSH-LADGPHEKSA-N 0.000 description 1
- NPVLNGDGGCBKPO-LMSSTIIKSA-N CC(C)(CCC1)[C@@H]1c(cc(COc1cccc([C@@H](CC(OC)=O)O)c1)cc1)c1-c1cc(OC)ccc1F Chemical compound CC(C)(CCC1)[C@@H]1c(cc(COc1cccc([C@@H](CC(OC)=O)O)c1)cc1)c1-c1cc(OC)ccc1F NPVLNGDGGCBKPO-LMSSTIIKSA-N 0.000 description 1
- KZGKKIDYHHGVKX-UHSQPCAPSA-N CC(C)(CCC1)[C@@H]1c(cc(COc1cccc([C@H](CC(O)=O)C2CC2)c1)cc1)c1-c1cc(C(F)F)ccc1F Chemical compound CC(C)(CCC1)[C@@H]1c(cc(COc1cccc([C@H](CC(O)=O)C2CC2)c1)cc1)c1-c1cc(C(F)F)ccc1F KZGKKIDYHHGVKX-UHSQPCAPSA-N 0.000 description 1
- NMINURRSCCQGKI-OFSOJUDTSA-N CC(C)(CCC1)[C@@H]1c(cc(COc1cccc([C@H](CC(O)=O)C2CC2)c1)cc1)c1-c1cc(OC)ccc1F Chemical compound CC(C)(CCC1)[C@@H]1c(cc(COc1cccc([C@H](CC(O)=O)C2CC2)c1)cc1)c1-c1cc(OC)ccc1F NMINURRSCCQGKI-OFSOJUDTSA-N 0.000 description 1
- JTKRHYPNPFKELU-OFSOJUDTSA-N CC(C)(CCC1)[C@@H]1c(cc(COc1cccc([C@H](CC(OC)=O)C2CC2)c1)cc1)c1-c1cc(C(F)F)ccc1F Chemical compound CC(C)(CCC1)[C@@H]1c(cc(COc1cccc([C@H](CC(OC)=O)C2CC2)c1)cc1)c1-c1cc(C(F)F)ccc1F JTKRHYPNPFKELU-OFSOJUDTSA-N 0.000 description 1
- GVMKDKMWUVSEIK-KRWDZBQOSA-N CC(C)(CCC1)[C@@H]1c1c(-c2cc(OC)ccc2F)c(F)cc(CCl)c1 Chemical compound CC(C)(CCC1)[C@@H]1c1c(-c2cc(OC)ccc2F)c(F)cc(CCl)c1 GVMKDKMWUVSEIK-KRWDZBQOSA-N 0.000 description 1
- JNIAJCPAPJHCMI-KRWDZBQOSA-N CC(C)(CCC1)[C@@H]1c1c(-c2cc(OC)ccc2F)c(F)cc(CO)c1 Chemical compound CC(C)(CCC1)[C@@H]1c1c(-c2cc(OC)ccc2F)c(F)cc(CO)c1 JNIAJCPAPJHCMI-KRWDZBQOSA-N 0.000 description 1
- LTKWTTPBFCEXJW-LLVKDONJSA-N CC(C)(CCC1)[C@H]1c(cc(C(OC)=O)c(F)c1)c1O Chemical compound CC(C)(CCC1)[C@H]1c(cc(C(OC)=O)c(F)c1)c1O LTKWTTPBFCEXJW-LLVKDONJSA-N 0.000 description 1
- BWAJPJAKHMTOBO-GOSISDBHSA-N CC(C)(CCC1)[C@H]1c(cc(CCl)cc1)c1-c1cc(C(F)F)ccc1F Chemical compound CC(C)(CCC1)[C@H]1c(cc(CCl)cc1)c1-c1cc(C(F)F)ccc1F BWAJPJAKHMTOBO-GOSISDBHSA-N 0.000 description 1
- WMVAFWMHOICRSH-ISKFKSNPSA-N CC(C)(CCC1)[C@H]1c(cc(COc(cccc1[C@@H](CC(O)=O)O)c1F)cc1)c1-c1cc(OC)ncc1F Chemical compound CC(C)(CCC1)[C@H]1c(cc(COc(cccc1[C@@H](CC(O)=O)O)c1F)cc1)c1-c1cc(OC)ncc1F WMVAFWMHOICRSH-ISKFKSNPSA-N 0.000 description 1
- RESWOSDUANUWDV-IXCJQBJRSA-N CC(C)(CCC1)[C@H]1c(cc(COc1cc([C@@H](CC(OC)=O)O)ccc1)cc1)c1-c1cc(C(F)F)ccc1F Chemical compound CC(C)(CCC1)[C@H]1c(cc(COc1cc([C@@H](CC(OC)=O)O)ccc1)cc1)c1-c1cc(C(F)F)ccc1F RESWOSDUANUWDV-IXCJQBJRSA-N 0.000 description 1
- JTKRHYPNPFKELU-POURPWNDSA-N CC(C)(CCC1)[C@H]1c(cc(COc1cc([C@H](CC(OC)=O)C2CC2)ccc1)cc1)c1-c1cc(C(F)F)ccc1F Chemical compound CC(C)(CCC1)[C@H]1c(cc(COc1cc([C@H](CC(OC)=O)C2CC2)ccc1)cc1)c1-c1cc(C(F)F)ccc1F JTKRHYPNPFKELU-POURPWNDSA-N 0.000 description 1
- NMINURRSCCQGKI-DINWUYGQSA-N CC(C)(CCC1)[C@H]1c(cc(COc1cccc(C(CC(O)=O)C2CC2)c1)cc1)c1-c1cc(OC)ccc1F Chemical compound CC(C)(CCC1)[C@H]1c(cc(COc1cccc(C(CC(O)=O)C2CC2)c1)cc1)c1-c1cc(OC)ccc1F NMINURRSCCQGKI-DINWUYGQSA-N 0.000 description 1
- YJIBAFSBFYQCFU-VPTMLEGASA-N CC(C)(CCC1)[C@H]1c(cc(COc1cccc(C(CC(OC)=O)C2CC2)c1)cc1)c1-c1cc(OC)ccc1F Chemical compound CC(C)(CCC1)[C@H]1c(cc(COc1cccc(C(CC(OC)=O)C2CC2)c1)cc1)c1-c1cc(OC)ccc1F YJIBAFSBFYQCFU-VPTMLEGASA-N 0.000 description 1
- WSACLGWLOUGJHE-XNMGPUDCSA-N CC(C)(CCC1)[C@H]1c(cc(COc1cccc([C@@H](CC(O)=O)O)c1)cc1)c1-c1cc(C(F)F)ccc1F Chemical compound CC(C)(CCC1)[C@H]1c(cc(COc1cccc([C@@H](CC(O)=O)O)c1)cc1)c1-c1cc(C(F)F)ccc1F WSACLGWLOUGJHE-XNMGPUDCSA-N 0.000 description 1
- DZNFAPNMPRGDBY-IXCJQBJRSA-N CC(C)(CCC1)[C@H]1c(cc(COc1cccc([C@@H](CC(O)=O)O)c1)cc1)c1-c1cc(OC)ccc1F Chemical compound CC(C)(CCC1)[C@H]1c(cc(COc1cccc([C@@H](CC(O)=O)O)c1)cc1)c1-c1cc(OC)ccc1F DZNFAPNMPRGDBY-IXCJQBJRSA-N 0.000 description 1
- PAMOFSHDYGFZLH-LOYHVIPDSA-N CC(C)(CCC1)[C@H]1c(cc(COc1cccc([C@@H](CC(O)=O)O)c1)cc1)c1-c1cccc(C2(C)OCCO2)c1 Chemical compound CC(C)(CCC1)[C@H]1c(cc(COc1cccc([C@@H](CC(O)=O)O)c1)cc1)c1-c1cccc(C2(C)OCCO2)c1 PAMOFSHDYGFZLH-LOYHVIPDSA-N 0.000 description 1
- KRNRIAWHATWPDW-QHPSHKFUSA-N CC(C)(CCC1)[C@H]1c(cc(COc1cccc([C@@H](CC(O)OC)O)c1F)cc1)c1-c1cc(OC)ncc1F Chemical compound CC(C)(CCC1)[C@H]1c(cc(COc1cccc([C@@H](CC(O)OC)O)c1F)cc1)c1-c1cc(OC)ncc1F KRNRIAWHATWPDW-QHPSHKFUSA-N 0.000 description 1
- NPVLNGDGGCBKPO-XRKRLSELSA-N CC(C)(CCC1)[C@H]1c(cc(COc1cccc([C@@H](CC(OC)=O)O)c1)cc1)c1-c1cc(OC)ccc1F Chemical compound CC(C)(CCC1)[C@H]1c(cc(COc1cccc([C@@H](CC(OC)=O)O)c1)cc1)c1-c1cc(OC)ccc1F NPVLNGDGGCBKPO-XRKRLSELSA-N 0.000 description 1
- MKWNKCCGQXZOMC-ZEQKJWHPSA-N CC(C)(CCC1)[C@H]1c(cc(COc1cccc([C@H](CC(N=O)=O)C2CC2)c1F)cc1)c1-c1cc(OC)ncc1F Chemical compound CC(C)(CCC1)[C@H]1c(cc(COc1cccc([C@H](CC(N=O)=O)C2CC2)c1F)cc1)c1-c1cc(OC)ncc1F MKWNKCCGQXZOMC-ZEQKJWHPSA-N 0.000 description 1
- KZGKKIDYHHGVKX-GGXMVOPNSA-N CC(C)(CCC1)[C@H]1c(cc(COc1cccc([C@H](CC(O)=O)C2CC2)c1)cc1)c1-c1cc(C(F)F)ccc1F Chemical compound CC(C)(CCC1)[C@H]1c(cc(COc1cccc([C@H](CC(O)=O)C2CC2)c1)cc1)c1-c1cc(C(F)F)ccc1F KZGKKIDYHHGVKX-GGXMVOPNSA-N 0.000 description 1
- KDNQVKHDXPDTNJ-ZQWAWDFXSA-N CC(C)(CCC1)[C@H]1c(cc(COc1cccc([C@H](CC(O)=O)C2CC2)c1)cc1)c1-c1cc(C2(C)OCCO2)ccc1 Chemical compound CC(C)(CCC1)[C@H]1c(cc(COc1cccc([C@H](CC(O)=O)C2CC2)c1)cc1)c1-c1cc(C2(C)OCCO2)ccc1 KDNQVKHDXPDTNJ-ZQWAWDFXSA-N 0.000 description 1
- QTLYCLHWIIYSLV-ZEQKJWHPSA-N CC(C)(CCC1)[C@H]1c(cc(COc1cccc([C@H](CC(O)=O)C2CC2)c1F)cc1)c1-c1cc(OC)ncc1F Chemical compound CC(C)(CCC1)[C@H]1c(cc(COc1cccc([C@H](CC(O)=O)C2CC2)c1F)cc1)c1-c1cc(OC)ncc1F QTLYCLHWIIYSLV-ZEQKJWHPSA-N 0.000 description 1
- IISZJGOERVJVIM-LEAFIULHSA-N CC(C)(CCC1)[C@H]1c(cc(COc1cccc([C@H](CC(OC)=O)C2CC2)c1F)cc1)c1-c(cc(C(F)F)cc1)c1F Chemical compound CC(C)(CCC1)[C@H]1c(cc(COc1cccc([C@H](CC(OC)=O)C2CC2)c1F)cc1)c1-c(cc(C(F)F)cc1)c1F IISZJGOERVJVIM-LEAFIULHSA-N 0.000 description 1
- GVMKDKMWUVSEIK-QGZVFWFLSA-N CC(C)(CCC1)[C@H]1c1c(-c2cc(OC)ccc2F)c(F)cc(CCl)c1 Chemical compound CC(C)(CCC1)[C@H]1c1c(-c2cc(OC)ccc2F)c(F)cc(CCl)c1 GVMKDKMWUVSEIK-QGZVFWFLSA-N 0.000 description 1
- JNIAJCPAPJHCMI-QGZVFWFLSA-N CC(C)(CCC1)[C@H]1c1c(-c2cc(OC)ccc2F)c(F)cc(CO)c1 Chemical compound CC(C)(CCC1)[C@H]1c1c(-c2cc(OC)ccc2F)c(F)cc(CO)c1 JNIAJCPAPJHCMI-QGZVFWFLSA-N 0.000 description 1
- XISHOUWIJMCLCW-GOSISDBHSA-N CC(C)(CCC1)[C@H]1c1cc(CCl)ccc1-c1cc(F)ccc1F Chemical compound CC(C)(CCC1)[C@H]1c1cc(CCl)ccc1-c1cc(F)ccc1F XISHOUWIJMCLCW-GOSISDBHSA-N 0.000 description 1
- HEESDCQSHHFWDE-IZEXYCQBSA-N CC(C)(CCCC1)[C@@H]1c(cc(COc1cc([C@@H](CC(O)=O)C2CC2)ccc1)cc1)c1-c1cc(OC)ccc1F Chemical compound CC(C)(CCCC1)[C@@H]1c(cc(COc1cc([C@@H](CC(O)=O)C2CC2)ccc1)cc1)c1-c1cc(OC)ccc1F HEESDCQSHHFWDE-IZEXYCQBSA-N 0.000 description 1
- HEESDCQSHHFWDE-MVSFAKPFSA-N CC(C)(CCCC1)[C@@H]1c(cc(COc1cc([C@H](CC(O)=O)C2CC2)ccc1)cc1)c1-c1cc(OC)ccc1F Chemical compound CC(C)(CCCC1)[C@@H]1c(cc(COc1cc([C@H](CC(O)=O)C2CC2)ccc1)cc1)c1-c1cc(OC)ccc1F HEESDCQSHHFWDE-MVSFAKPFSA-N 0.000 description 1
- RAXQHEXRHOMYBP-NGQVCNFZSA-N CC(C)(CCCC1)[C@@H]1c(cc(COc1cccc([C@@H](CC2CC2)CC(O)=O)c1F)cc1)c1-c1cc(OC)ccc1F Chemical compound CC(C)(CCCC1)[C@@H]1c(cc(COc1cccc([C@@H](CC2CC2)CC(O)=O)c1F)cc1)c1-c1cc(OC)ccc1F RAXQHEXRHOMYBP-NGQVCNFZSA-N 0.000 description 1
- RAXQHEXRHOMYBP-HLADLETHSA-N CC(C)(CCCC1)[C@@H]1c(cc(COc1cccc([C@H](CC2CC2)CC(O)=O)c1F)cc1)c1-c1cc(OC)ccc1F Chemical compound CC(C)(CCCC1)[C@@H]1c(cc(COc1cccc([C@H](CC2CC2)CC(O)=O)c1F)cc1)c1-c1cc(OC)ccc1F RAXQHEXRHOMYBP-HLADLETHSA-N 0.000 description 1
- RFXLUPUEIJFFDV-FQEVSTJZSA-N CC(C)(CCCC1)[C@@H]1c1cc(CCl)ccc1-c1cc(OC)ccc1F Chemical compound CC(C)(CCCC1)[C@@H]1c1cc(CCl)ccc1-c1cc(OC)ccc1F RFXLUPUEIJFFDV-FQEVSTJZSA-N 0.000 description 1
- RAXQHEXRHOMYBP-QABMSTFYSA-N CC(C)(CCCC1)[C@H]1c(cc(COc(cccc1[C@@H](CC2CC2)CC(O)=O)c1F)cc1)c1-c1cc(OC)ccc1F Chemical compound CC(C)(CCCC1)[C@H]1c(cc(COc(cccc1[C@@H](CC2CC2)CC(O)=O)c1F)cc1)c1-c1cc(OC)ccc1F RAXQHEXRHOMYBP-QABMSTFYSA-N 0.000 description 1
- RAXQHEXRHOMYBP-AYWVHJORSA-N CC(C)(CCCC1)[C@H]1c(cc(COc(cccc1[C@H](CC2CC2)CC(O)=O)c1F)cc1)c1-c1cc(OC)ccc1F Chemical compound CC(C)(CCCC1)[C@H]1c(cc(COc(cccc1[C@H](CC2CC2)CC(O)=O)c1F)cc1)c1-c1cc(OC)ccc1F RAXQHEXRHOMYBP-AYWVHJORSA-N 0.000 description 1
- HEESDCQSHHFWDE-GRKNLSHJSA-N CC(C)(CCCC1)[C@H]1c(cc(COc1cccc([C@H](CC(O)=O)C2CC2)c1)cc1)c1-c(cc(cc1)OC)c1F Chemical compound CC(C)(CCCC1)[C@H]1c(cc(COc1cccc([C@H](CC(O)=O)C2CC2)c1)cc1)c1-c(cc(cc1)OC)c1F HEESDCQSHHFWDE-GRKNLSHJSA-N 0.000 description 1
- RFXLUPUEIJFFDV-HXUWFJFHSA-N CC(C)(CCCC1)[C@H]1c1cc(CCl)ccc1-c(cc(cc1)OC)c1F Chemical compound CC(C)(CCCC1)[C@H]1c1cc(CCl)ccc1-c(cc(cc1)OC)c1F RFXLUPUEIJFFDV-HXUWFJFHSA-N 0.000 description 1
- LXVPGTFDBNISSK-UHFFFAOYSA-N CC(C)(OC(C1=C(C)c2cc(OCc3ccccc3)ccc2)=O)OC1=O Chemical compound CC(C)(OC(C1=C(C)c2cc(OCc3ccccc3)ccc2)=O)OC1=O LXVPGTFDBNISSK-UHFFFAOYSA-N 0.000 description 1
- ZAOMBWGWRYLNEV-UHFFFAOYSA-N CC(C)(OC(C1=Cc(cccc2OC)c2F)=O)OC1=O Chemical compound CC(C)(OC(C1=Cc(cccc2OC)c2F)=O)OC1=O ZAOMBWGWRYLNEV-UHFFFAOYSA-N 0.000 description 1
- LCLVJNFWTMYFRL-UHFFFAOYSA-N CC(C)(OC(C1=Cc2cc(O)ccc2)=O)OC1=O Chemical compound CC(C)(OC(C1=Cc2cc(O)ccc2)=O)OC1=O LCLVJNFWTMYFRL-UHFFFAOYSA-N 0.000 description 1
- JRQLEKRVRVVAME-UHFFFAOYSA-N CC(C)(OC(C1C(C2CC2)c2cc(O)ccc2)=O)OC1=O Chemical compound CC(C)(OC(C1C(C2CC2)c2cc(O)ccc2)=O)OC1=O JRQLEKRVRVVAME-UHFFFAOYSA-N 0.000 description 1
- HYTUMJCQJVNYKX-UHFFFAOYSA-N CC(C)(OC(C1C(CC=C)c2cc(O)ccc2)=O)OC1=O Chemical compound CC(C)(OC(C1C(CC=C)c2cc(O)ccc2)=O)OC1=O HYTUMJCQJVNYKX-UHFFFAOYSA-N 0.000 description 1
- OLGDJYLKBMQPIY-UHFFFAOYSA-N CC(C)=C(C)c1cc(C(OC)=O)ccc1-c1cc(OC)ccc1F Chemical compound CC(C)=C(C)c1cc(C(OC)=O)ccc1-c1cc(OC)ccc1F OLGDJYLKBMQPIY-UHFFFAOYSA-N 0.000 description 1
- MIORPKIVKXZDFV-UHFFFAOYSA-N CC(C)=CCOCc(cc(CBr)cc1)c1-c1cc(OC)ccc1F Chemical compound CC(C)=CCOCc(cc(CBr)cc1)c1-c1cc(OC)ccc1F MIORPKIVKXZDFV-UHFFFAOYSA-N 0.000 description 1
- JMZOCMDIGWFTIL-UHFFFAOYSA-N CC(C)=CCOCc(cc(CO)cc1)c1-c1cc(OC)ccc1F Chemical compound CC(C)=CCOCc(cc(CO)cc1)c1-c1cc(OC)ccc1F JMZOCMDIGWFTIL-UHFFFAOYSA-N 0.000 description 1
- VQPWVSYTUSGKLB-IBGZPJMESA-N CC(C)COc1cc(COc2cc([C@@H](C)CC(O)=O)ccc2)ccc1-c1cc(OC)ccc1F Chemical compound CC(C)COc1cc(COc2cc([C@@H](C)CC(O)=O)ccc2)ccc1-c1cc(OC)ccc1F VQPWVSYTUSGKLB-IBGZPJMESA-N 0.000 description 1
- VQPWVSYTUSGKLB-LJQANCHMSA-N CC(C)COc1cc(COc2cccc([C@H](C)CC(O)=O)c2)ccc1-c1cc(OC)ccc1F Chemical compound CC(C)COc1cc(COc2cccc([C@H](C)CC(O)=O)c2)ccc1-c1cc(OC)ccc1F VQPWVSYTUSGKLB-LJQANCHMSA-N 0.000 description 1
- PSENHFXCTOGLMY-GOSISDBHSA-N CC(C)Oc1cc(COc2cc([C@H](C)CC(O)=O)ccc2)ccc1-c1cc(OC)ccc1F Chemical compound CC(C)Oc1cc(COc2cc([C@H](C)CC(O)=O)ccc2)ccc1-c1cc(OC)ccc1F PSENHFXCTOGLMY-GOSISDBHSA-N 0.000 description 1
- PSENHFXCTOGLMY-SFHVURJKSA-N CC(C)Oc1cc(COc2cccc([C@@H](C)CC(O)=O)c2)ccc1-c1cc(OC)ccc1F Chemical compound CC(C)Oc1cc(COc2cccc([C@@H](C)CC(O)=O)c2)ccc1-c1cc(OC)ccc1F PSENHFXCTOGLMY-SFHVURJKSA-N 0.000 description 1
- RQSUZUAQZWNSIS-UHFFFAOYSA-N CC(CCC1)C1c(cc(CCl)cc1)c1-c1cc(OC)ccc1F Chemical compound CC(CCC1)C1c(cc(CCl)cc1)c1-c1cc(OC)ccc1F RQSUZUAQZWNSIS-UHFFFAOYSA-N 0.000 description 1
- IEBMORAAWOWTQQ-UHFFFAOYSA-N CC(CCC1)C1c(cc(cc1)C(OC)=O)c1-c1cc(OC)ccc1F Chemical compound CC(CCC1)C1c(cc(cc1)C(OC)=O)c1-c1cc(OC)ccc1F IEBMORAAWOWTQQ-UHFFFAOYSA-N 0.000 description 1
- AKBGZQUMEYFTIU-UHFFFAOYSA-N CC(CCC1=O)=C1c(cc(cc1)C(OC)=O)c1-c1cc(OC)ccc1F Chemical compound CC(CCC1=O)=C1c(cc(cc1)C(OC)=O)c1-c1cc(OC)ccc1F AKBGZQUMEYFTIU-UHFFFAOYSA-N 0.000 description 1
- CZTMUXJYPAJKRG-UHFFFAOYSA-N CC(CCC1=O)C1c1cc(C(OC)=O)ccc1-c1cc(OC)ccc1F Chemical compound CC(CCC1=O)C1c1cc(C(OC)=O)ccc1-c1cc(OC)ccc1F CZTMUXJYPAJKRG-UHFFFAOYSA-N 0.000 description 1
- VFZOBGXUPKMJLY-FUEXJSSKSA-N CC/C=C/[C@@H](CC(OC)=O)c1cccc(O)c1 Chemical compound CC/C=C/[C@@H](CC(OC)=O)c1cccc(O)c1 VFZOBGXUPKMJLY-FUEXJSSKSA-N 0.000 description 1
- XDMSAUNSTJSUOM-UHFFFAOYSA-N CC1(C)C(c(cc(C(OC)=O)c(F)c2)c2-c2cc(OC)ccc2F)=CCC1 Chemical compound CC1(C)C(c(cc(C(OC)=O)c(F)c2)c2-c2cc(OC)ccc2F)=CCC1 XDMSAUNSTJSUOM-UHFFFAOYSA-N 0.000 description 1
- CFPHYEYBHVYQNN-UHFFFAOYSA-N CC1(C)C(c(cc(C(OC)=O)c(F)c2)c2O)=CCC1 Chemical compound CC1(C)C(c(cc(C(OC)=O)c(F)c2)c2O)=CCC1 CFPHYEYBHVYQNN-UHFFFAOYSA-N 0.000 description 1
- DMEOJMQVXJDKEE-RUZDIDTESA-N CC1(C)C(c(cc(COc2cc([C@H](CC3CC3)CC(O)=O)ccc2)cc2)c2-c2cc(OC)ccc2F)=CCC1 Chemical compound CC1(C)C(c(cc(COc2cc([C@H](CC3CC3)CC(O)=O)ccc2)cc2)c2-c2cc(OC)ccc2F)=CCC1 DMEOJMQVXJDKEE-RUZDIDTESA-N 0.000 description 1
- CCEKKCCPQJDORS-ZZTVPSNHSA-N CC1(C)C(c(cc(COc2cccc([C@@H](CC(OC)=O)O)c2)cc2)c2-c2cc(OC)ccc2F)(O)OCCC1 Chemical compound CC1(C)C(c(cc(COc2cccc([C@@H](CC(OC)=O)O)c2)cc2)c2-c2cc(OC)ccc2F)(O)OCCC1 CCEKKCCPQJDORS-ZZTVPSNHSA-N 0.000 description 1
- DMEOJMQVXJDKEE-VWLOTQADSA-N CC1(C)C(c(cc(COc2cccc([C@@H](CC3CC3)CC(O)=O)c2)cc2)c2-c2cc(OC)ccc2F)=CCC1 Chemical compound CC1(C)C(c(cc(COc2cccc([C@@H](CC3CC3)CC(O)=O)c2)cc2)c2-c2cc(OC)ccc2F)=CCC1 DMEOJMQVXJDKEE-VWLOTQADSA-N 0.000 description 1
- LCZHXRQYNKSOPN-WJOKGBTCSA-N CC1(C)C(c(cc(COc2cccc([C@H](CC(O)=O)C3CC3)c2)cc2)c2-c2cc(C3(C)OCCO3)ccc2)=CCC1 Chemical compound CC1(C)C(c(cc(COc2cccc([C@H](CC(O)=O)C3CC3)c2)cc2)c2-c2cc(C3(C)OCCO3)ccc2)=CCC1 LCZHXRQYNKSOPN-WJOKGBTCSA-N 0.000 description 1
- WHLCOOXPWJYKBO-TUDONDPESA-N CC1(C)C(c(cc(COc2cccc([C@H](CC(OC)=O)C3CC3)c2)cc2)c2-c(cc(cc2)OC)c2F)OCCC1 Chemical compound CC1(C)C(c(cc(COc2cccc([C@H](CC(OC)=O)C3CC3)c2)cc2)c2-c(cc(cc2)OC)c2F)OCCC1 WHLCOOXPWJYKBO-TUDONDPESA-N 0.000 description 1
- OKLKGDNOAPNKJM-JSAORFSISA-N CC1(C)C(c(cc(COc2cccc([C@H](CC(OC)=O)C3CC3)c2)cc2)c2-c2cc(OC)ccc2F)(O)OCCC1 Chemical compound CC1(C)C(c(cc(COc2cccc([C@H](CC(OC)=O)C3CC3)c2)cc2)c2-c2cc(OC)ccc2F)(O)OCCC1 OKLKGDNOAPNKJM-JSAORFSISA-N 0.000 description 1
- VTNWHMAITTZHRZ-UHFFFAOYSA-N CC1(C)C(c(cc(cc2)C(O)=O)c2-c(cc(cc2)O)c2F)=CCC1 Chemical compound CC1(C)C(c(cc(cc2)C(O)=O)c2-c(cc(cc2)O)c2F)=CCC1 VTNWHMAITTZHRZ-UHFFFAOYSA-N 0.000 description 1
- UUKCWGAEALTDDS-UHFFFAOYSA-N CC1(C)C(c(cc(cc2)C(OC)=O)c2-c2cc(C(F)(F)F)ccc2F)=CCC1 Chemical compound CC1(C)C(c(cc(cc2)C(OC)=O)c2-c2cc(C(F)(F)F)ccc2F)=CCC1 UUKCWGAEALTDDS-UHFFFAOYSA-N 0.000 description 1
- KGSBVZRQJFWTDH-UHFFFAOYSA-N CC1(C)C(c2cc(C(OC)=O)ccc2-c(cc(cc2)O)c2F)=CCC1 Chemical compound CC1(C)C(c2cc(C(OC)=O)ccc2-c(cc(cc2)O)c2F)=CCC1 KGSBVZRQJFWTDH-UHFFFAOYSA-N 0.000 description 1
- BCABDQOVQDKWDH-UHFFFAOYSA-N CC1(C)C(c2cc(CO)ccc2-c2cc(C(F)(F)F)ccc2F)=CCC1 Chemical compound CC1(C)C(c2cc(CO)ccc2-c2cc(C(F)(F)F)ccc2F)=CCC1 BCABDQOVQDKWDH-UHFFFAOYSA-N 0.000 description 1
- ZDCGXZXPCDUNGG-MHZLTWQESA-N CC1(C)CC(c(cc(COc2cccc([C@@H](CC3CC3)CC(O)=O)c2)cc2)c2-c2cc(OC)ccc2F)=CC(C)(C)C1 Chemical compound CC1(C)CC(c(cc(COc2cccc([C@@H](CC3CC3)CC(O)=O)c2)cc2)c2-c2cc(OC)ccc2F)=CC(C)(C)C1 ZDCGXZXPCDUNGG-MHZLTWQESA-N 0.000 description 1
- ZDCGXZXPCDUNGG-HHHXNRCGSA-N CC1(C)CC(c(cc(COc2cccc([C@H](CC3CC3)CC(O)=O)c2)cc2)c2-c2cc(OC)ccc2F)=CC(C)(C)C1 Chemical compound CC1(C)CC(c(cc(COc2cccc([C@H](CC3CC3)CC(O)=O)c2)cc2)c2-c2cc(OC)ccc2F)=CC(C)(C)C1 ZDCGXZXPCDUNGG-HHHXNRCGSA-N 0.000 description 1
- DOSGEBYQRMBTGS-UHFFFAOYSA-N CC1(C)OB(C2=CCOCC2)OC1(C)C Chemical compound CC1(C)OB(C2=CCOCC2)OC1(C)C DOSGEBYQRMBTGS-UHFFFAOYSA-N 0.000 description 1
- POLFBNSFHWHAPF-UHFFFAOYSA-N CC1(C)OS(c2cc(OC(F)F)ccc2)OC1(C)C Chemical compound CC1(C)OS(c2cc(OC(F)F)ccc2)OC1(C)C POLFBNSFHWHAPF-UHFFFAOYSA-N 0.000 description 1
- VCMQSSIUZXWCMZ-XYFRODSISA-N CC1C(OCc(cc2)cc(CN3CCCCC3)c2-c2cc(C)ccc2F)=CC=CC1[C@H](CC(O)=O)C1CC1 Chemical compound CC1C(OCc(cc2)cc(CN3CCCCC3)c2-c2cc(C)ccc2F)=CC=CC1[C@H](CC(O)=O)C1CC1 VCMQSSIUZXWCMZ-XYFRODSISA-N 0.000 description 1
- VMDFMPDOJGMCIB-AXDSSHIGSA-N CC1C([C@@H](CC(OC)=O)COC)=CC(O)=CC1 Chemical compound CC1C([C@@H](CC(OC)=O)COC)=CC(O)=CC1 VMDFMPDOJGMCIB-AXDSSHIGSA-N 0.000 description 1
- XZOYMSOUTYYRNG-UHFFFAOYSA-N CCC(C)(C(C(OC(C)(C)O1)=O)C1=O)c1cc(OCc2ccccc2)ccc1 Chemical compound CCC(C)(C(C(OC(C)(C)O1)=O)C1=O)c1cc(OCc2ccccc2)ccc1 XZOYMSOUTYYRNG-UHFFFAOYSA-N 0.000 description 1
- AZMOAEOMJRGMBC-UHFFFAOYSA-N CCC(CC(O)=O)c1cccc(OC)c1F Chemical compound CCC(CC(O)=O)c1cccc(OC)c1F AZMOAEOMJRGMBC-UHFFFAOYSA-N 0.000 description 1
- IHOLJWKTLJJEJS-WJOKGBTCSA-N CCCCCCNCc(cc(COc1cc([C@H](CC(OC)=O)C2CC2)ccc1)cc1)c1-c1cc(OC)ccc1F Chemical compound CCCCCCNCc(cc(COc1cc([C@H](CC(OC)=O)C2CC2)ccc1)cc1)c1-c1cc(OC)ccc1F IHOLJWKTLJJEJS-WJOKGBTCSA-N 0.000 description 1
- ZNIUZZFHTLKBAH-UHFFFAOYSA-N CCCCOc(cc(CCl)cc1)c1-c(cc(cc1)OC)c1F Chemical compound CCCCOc(cc(CCl)cc1)c1-c(cc(cc1)OC)c1F ZNIUZZFHTLKBAH-UHFFFAOYSA-N 0.000 description 1
- NMEFHXAYVZFSCM-HXUWFJFHSA-N CCCCOc(cc(COc1cc([C@H](C)CC(O)=O)ccc1)cc1)c1-c1cc(OCC)ccc1F Chemical compound CCCCOc(cc(COc1cc([C@H](C)CC(O)=O)ccc1)cc1)c1-c1cc(OCC)ccc1F NMEFHXAYVZFSCM-HXUWFJFHSA-N 0.000 description 1
- NMEFHXAYVZFSCM-FQEVSTJZSA-N CCCCOc(cc(COc1cccc([C@@H](C)CC(O)=O)c1)cc1)c1-c1cc(OCC)ccc1F Chemical compound CCCCOc(cc(COc1cccc([C@@H](C)CC(O)=O)c1)cc1)c1-c1cc(OCC)ccc1F NMEFHXAYVZFSCM-FQEVSTJZSA-N 0.000 description 1
- GLAOJSWDHUUMDV-BPADPFCFSA-N CCCCOc(cc(COc1cccc([C@H](C)CC(OC)=O)c1)cc1)c1C(CC(C)(C=C1)OC)=C1F Chemical compound CCCCOc(cc(COc1cccc([C@H](C)CC(OC)=O)c1)cc1)c1C(CC(C)(C=C1)OC)=C1F GLAOJSWDHUUMDV-BPADPFCFSA-N 0.000 description 1
- KWAXTRTZFIPJQE-UHFFFAOYSA-N CCCCOc(ccc(OC)c1)c1-c1ccc(COc2cc(CCC(OC)=O)ccc2)cc1C Chemical compound CCCCOc(ccc(OC)c1)c1-c1ccc(COc2cc(CCC(OC)=O)ccc2)cc1C KWAXTRTZFIPJQE-UHFFFAOYSA-N 0.000 description 1
- SJAJRVDKGMIIHT-LBPRGKRZSA-N CCCC[C@@H](CC(OC)=O)c1cc(O)ccc1 Chemical compound CCCC[C@@H](CC(OC)=O)c1cc(O)ccc1 SJAJRVDKGMIIHT-LBPRGKRZSA-N 0.000 description 1
- SJAJRVDKGMIIHT-GFCCVEGCSA-N CCCC[C@H](CC(OC)=O)c1cc(O)ccc1 Chemical compound CCCC[C@H](CC(OC)=O)c1cc(O)ccc1 SJAJRVDKGMIIHT-GFCCVEGCSA-N 0.000 description 1
- LOMLLYDVQRQYKT-ACXKHFGCSA-N CCC[C@@H](CC(O)=O)c1cccc(OCc(cc2)cc(C3C(C)(C)CCC3)c2-c2cc(OC)ccc2)c1 Chemical compound CCC[C@@H](CC(O)=O)c1cccc(OCc(cc2)cc(C3C(C)(C)CCC3)c2-c2cc(OC)ccc2)c1 LOMLLYDVQRQYKT-ACXKHFGCSA-N 0.000 description 1
- LOMLLYDVQRQYKT-LZDHLTRGSA-N CCC[C@H](CC(O)=O)c1cc(OCc(cc2)cc(C3C(C)(C)CCC3)c2-c2cc(OC)ccc2)ccc1 Chemical compound CCC[C@H](CC(O)=O)c1cc(OCc(cc2)cc(C3C(C)(C)CCC3)c2-c2cc(OC)ccc2)ccc1 LOMLLYDVQRQYKT-LZDHLTRGSA-N 0.000 description 1
- CZANAJCJIRWTPU-SNVBAGLBSA-N CCC[C@H](CC(OC)=O)c1cc(O)ccc1 Chemical compound CCC[C@H](CC(OC)=O)c1cc(O)ccc1 CZANAJCJIRWTPU-SNVBAGLBSA-N 0.000 description 1
- CFAFRJZREDJECW-UHFFFAOYSA-N CCOC(C(C)Cc1cccc(O)c1)=O Chemical compound CCOC(C(C)Cc1cccc(O)c1)=O CFAFRJZREDJECW-UHFFFAOYSA-N 0.000 description 1
- KFYJLRXQQRXINW-CYBMUJFWSA-N CCOC(C[C@@H](CC1CC1)c1cc(O)ccc1)=O Chemical compound CCOC(C[C@@H](CC1CC1)c1cc(O)ccc1)=O KFYJLRXQQRXINW-CYBMUJFWSA-N 0.000 description 1
- PYPLNVZECZLNJQ-RUZDIDTESA-N CCOC(C[C@@H](CC1CC1)c1cccc(OCc(cc2)cc(S(C(C)C)(=O)=O)c2-c2cc(OC)ccc2F)c1)=O Chemical compound CCOC(C[C@@H](CC1CC1)c1cccc(OCc(cc2)cc(S(C(C)C)(=O)=O)c2-c2cc(OC)ccc2F)c1)=O PYPLNVZECZLNJQ-RUZDIDTESA-N 0.000 description 1
- SHPWXCPJTFJWJY-RUZDIDTESA-N CCOC(C[C@@H](CC1CC1)c1cccc(OCc(cc2)cc(SC(C)C)c2-c2cc(OC)ccc2F)c1)=O Chemical compound CCOC(C[C@@H](CC1CC1)c1cccc(OCc(cc2)cc(SC(C)C)c2-c2cc(OC)ccc2F)c1)=O SHPWXCPJTFJWJY-RUZDIDTESA-N 0.000 description 1
- KFYJLRXQQRXINW-ZDUSSCGKSA-N CCOC(C[C@H](CC1CC1)c1cc(O)ccc1)=O Chemical compound CCOC(C[C@H](CC1CC1)c1cc(O)ccc1)=O KFYJLRXQQRXINW-ZDUSSCGKSA-N 0.000 description 1
- GRJCJRZRKUEXLU-FQEVSTJZSA-N CC[C@@H](CC(O)=O)c1cccc(OCc(cc2)cc(C3=CCCC3(C)C)c2-c2cc(C(F)F)ccc2F)c1F Chemical compound CC[C@@H](CC(O)=O)c1cccc(OCc(cc2)cc(C3=CCCC3(C)C)c2-c2cc(C(F)F)ccc2F)c1F GRJCJRZRKUEXLU-FQEVSTJZSA-N 0.000 description 1
- PWUHPFYECPZSIT-NRFANRHFSA-N CC[C@@H](CC(OC)=O)c(cccc1OCc(cc2)cc(C3=CCCC3(C)C)c2-c2cc(C(F)F)ccc2F)c1F Chemical compound CC[C@@H](CC(OC)=O)c(cccc1OCc(cc2)cc(C3=CCCC3(C)C)c2-c2cc(C(F)F)ccc2F)c1F PWUHPFYECPZSIT-NRFANRHFSA-N 0.000 description 1
- APYKJHDCYFIQJM-VIFPVBQESA-N CC[C@@H](CC(OC)=O)c1cc(O)ccc1 Chemical compound CC[C@@H](CC(OC)=O)c1cc(O)ccc1 APYKJHDCYFIQJM-VIFPVBQESA-N 0.000 description 1
- OJTNELIBKBVZNH-VIFPVBQESA-N CC[C@@H](CC(OC)=O)c1cccc(ON)c1 Chemical compound CC[C@@H](CC(OC)=O)c1cccc(ON)c1 OJTNELIBKBVZNH-VIFPVBQESA-N 0.000 description 1
- GRJCJRZRKUEXLU-HXUWFJFHSA-N CC[C@H](CC(O)=O)c(cccc1OCc(cc2)cc(C3=CCCC3(C)C)c2-c2cc(C(F)F)ccc2F)c1F Chemical compound CC[C@H](CC(O)=O)c(cccc1OCc(cc2)cc(C3=CCCC3(C)C)c2-c2cc(C(F)F)ccc2F)c1F GRJCJRZRKUEXLU-HXUWFJFHSA-N 0.000 description 1
- PWUHPFYECPZSIT-OAQYLSRUSA-N CC[C@H](CC(OC)=O)c(cccc1OCc(cc2)cc(C3=CCCC3(C)C)c2-c2cc(C(F)F)ccc2F)c1F Chemical compound CC[C@H](CC(OC)=O)c(cccc1OCc(cc2)cc(C3=CCCC3(C)C)c2-c2cc(C(F)F)ccc2F)c1F PWUHPFYECPZSIT-OAQYLSRUSA-N 0.000 description 1
- OJTNELIBKBVZNH-SECBINFHSA-N CC[C@H](CC(OC)=O)c1cccc(ON)c1 Chemical compound CC[C@H](CC(OC)=O)c1cccc(ON)c1 OJTNELIBKBVZNH-SECBINFHSA-N 0.000 description 1
- SJVOVPFASBAPKF-UHFFFAOYSA-N COC(C1)C=CC(F)=C1c(ccc(CO)c1)c1N1CCCCC1 Chemical compound COC(C1)C=CC(F)=C1c(ccc(CO)c1)c1N1CCCCC1 SJVOVPFASBAPKF-UHFFFAOYSA-N 0.000 description 1
- HQOCEKXLRYIHME-GLGOKHISSA-N COC(C1)[C@]1(CC(OC)=O)c1cc(O)ccc1 Chemical compound COC(C1)[C@]1(CC(OC)=O)c1cc(O)ccc1 HQOCEKXLRYIHME-GLGOKHISSA-N 0.000 description 1
- CHKLVIDPLMAEFW-LRBNCQHVSA-N COC(C=CC1F)=CC1c1c(CN2CCCCC2)cc(COc2cc([C@@H](CC(O)=O)C3CC3)ccc2)cc1 Chemical compound COC(C=CC1F)=CC1c1c(CN2CCCCC2)cc(COc2cc([C@@H](CC(O)=O)C3CC3)ccc2)cc1 CHKLVIDPLMAEFW-LRBNCQHVSA-N 0.000 description 1
- IIFOKIAATXLZIB-UHFFFAOYSA-N COC(CCc1cccc(O)c1)=O Chemical compound COC(CCc1cccc(O)c1)=O IIFOKIAATXLZIB-UHFFFAOYSA-N 0.000 description 1
- QZKQLBSONQGOEI-UHFFFAOYSA-N COC(CCc1cccc(OCc(cc2C3=CCCC3)ccc2-c(cc(cc2)OC)c2N)c1)=O Chemical compound COC(CCc1cccc(OCc(cc2C3=CCCC3)ccc2-c(cc(cc2)OC)c2N)c1)=O QZKQLBSONQGOEI-UHFFFAOYSA-N 0.000 description 1
- IFCDEBLMEJIWSV-UHFFFAOYSA-N COC(CCc1cccc(OCc2ccc(-c(cc(cc3)OC)c3N)c(N)c2)c1)=O Chemical compound COC(CCc1cccc(OCc2ccc(-c(cc(cc3)OC)c3N)c(N)c2)c1)=O IFCDEBLMEJIWSV-UHFFFAOYSA-N 0.000 description 1
- PXBFBXFVUPMAJK-LBPRGKRZSA-N COC(C[C@@H](C1CC1)c1cccc(O)c1)=O Chemical compound COC(C[C@@H](C1CC1)c1cccc(O)c1)=O PXBFBXFVUPMAJK-LBPRGKRZSA-N 0.000 description 1
- DYNGMOSTHNWWAT-JTQLQIEISA-N COC(C[C@@H](C1CC1)c1cccc(O)c1F)=O Chemical compound COC(C[C@@H](C1CC1)c1cccc(O)c1F)=O DYNGMOSTHNWWAT-JTQLQIEISA-N 0.000 description 1
- GHRMPBBAUYJVQW-PMERELPUSA-N COC(C[C@@H](C1CC1)c1cccc(OCc(cc2)cc(CN3CCCCC3)c2-c2cc(OC)ccc2F)c1)=O Chemical compound COC(C[C@@H](C1CC1)c1cccc(OCc(cc2)cc(CN3CCCCC3)c2-c2cc(OC)ccc2F)c1)=O GHRMPBBAUYJVQW-PMERELPUSA-N 0.000 description 1
- PXBFBXFVUPMAJK-GFCCVEGCSA-N COC(C[C@H](C1CC1)c1cccc(O)c1)=O Chemical compound COC(C[C@H](C1CC1)c1cccc(O)c1)=O PXBFBXFVUPMAJK-GFCCVEGCSA-N 0.000 description 1
- HUXPCBCILWAAMR-JTQLQIEISA-N COC(C[C@H](CC=C)c1cc(O)ccc1)=O Chemical compound COC(C[C@H](CC=C)c1cc(O)ccc1)=O HUXPCBCILWAAMR-JTQLQIEISA-N 0.000 description 1
- DRUFUUXPRULILR-UHFFFAOYSA-N COC(c(c(F)c1)cc(Br)c1O)=O Chemical compound COC(c(c(F)c1)cc(Br)c1O)=O DRUFUUXPRULILR-UHFFFAOYSA-N 0.000 description 1
- JXAIHIFFAOHLQL-UHFFFAOYSA-N COC(c(c(F)c1)cc(Br)c1OC1OCCCC1)=O Chemical compound COC(c(c(F)c1)cc(Br)c1OC1OCCCC1)=O JXAIHIFFAOHLQL-UHFFFAOYSA-N 0.000 description 1
- PITHRGXNQCILJK-UHFFFAOYSA-N COC(c(cc(cc1)C(O)=O)c1-c(cc(cc1)F)c1F)=O Chemical compound COC(c(cc(cc1)C(O)=O)c1-c(cc(cc1)F)c1F)=O PITHRGXNQCILJK-UHFFFAOYSA-N 0.000 description 1
- RKUNSPWAQIUGEZ-UHFFFAOYSA-N COC(c(cc1)cc(Br)c1O)=O Chemical compound COC(c(cc1)cc(Br)c1O)=O RKUNSPWAQIUGEZ-UHFFFAOYSA-N 0.000 description 1
- PYDCHQSFLBMHLD-UHFFFAOYSA-N COC(c(cc1)cc(Br)c1OCc1ccccc1)=O Chemical compound COC(c(cc1)cc(Br)c1OCc1ccccc1)=O PYDCHQSFLBMHLD-UHFFFAOYSA-N 0.000 description 1
- FKXWAGAWFQMTOL-UHFFFAOYSA-N COC(c(cc1)cc(C(C2CC2)=O)c1OS(C(F)(F)F)(=O)=O)=O Chemical compound COC(c(cc1)cc(C(C2CC2)=O)c1OS(C(F)(F)F)(=O)=O)=O FKXWAGAWFQMTOL-UHFFFAOYSA-N 0.000 description 1
- PTWPQWNEULTLBJ-UHFFFAOYSA-N COC(c(cc1)cc(C2=CCOCC2)c1O)=O Chemical compound COC(c(cc1)cc(C2=CCOCC2)c1O)=O PTWPQWNEULTLBJ-UHFFFAOYSA-N 0.000 description 1
- NZBHMMBXNAEFPB-UHFFFAOYSA-N COC(c(cc1)cc(C2=CCOCC2)c1OC1OCCCC1)=O Chemical compound COC(c(cc1)cc(C2=CCOCC2)c1OC1OCCCC1)=O NZBHMMBXNAEFPB-UHFFFAOYSA-N 0.000 description 1
- TXKGRTUPOFEIEJ-UHFFFAOYSA-N COC(c(cc1C(C2CC2)=O)ccc1O)=O Chemical compound COC(c(cc1C(C2CC2)=O)ccc1O)=O TXKGRTUPOFEIEJ-UHFFFAOYSA-N 0.000 description 1
- BDOQMXMXZNLTLL-UHFFFAOYSA-N COC(c1ccc(-c2cc(OC)ccc2)c(C2=CCCCCC2)c1)=O Chemical compound COC(c1ccc(-c2cc(OC)ccc2)c(C2=CCCCCC2)c1)=O BDOQMXMXZNLTLL-UHFFFAOYSA-N 0.000 description 1
- YKMXXZGJJTYMDO-UHFFFAOYSA-N COC(c1ccc(-c2cc(OC)ccc2F)c(I)c1)=O Chemical compound COC(c1ccc(-c2cc(OC)ccc2F)c(I)c1)=O YKMXXZGJJTYMDO-UHFFFAOYSA-N 0.000 description 1
- DYTCGXGOJHEKMS-UHFFFAOYSA-N COCC(CC(OC)=O)c1cc(O)ccc1 Chemical compound COCC(CC(OC)=O)c1cc(O)ccc1 DYTCGXGOJHEKMS-UHFFFAOYSA-N 0.000 description 1
- XIRQHUKBZVUJOM-UHFFFAOYSA-N COCc(cc1)cc(C2=CCOCC2)c1-c1cc(OC)ccc1N Chemical compound COCc(cc1)cc(C2=CCOCC2)c1-c1cc(OC)ccc1N XIRQHUKBZVUJOM-UHFFFAOYSA-N 0.000 description 1
- TVJPJUUSTDCEJY-UHFFFAOYSA-N COc(cc1)cc(-c(ccc(C(O)=O)c2)c2N2CCCCC2)c1F Chemical compound COc(cc1)cc(-c(ccc(C(O)=O)c2)c2N2CCCCC2)c1F TVJPJUUSTDCEJY-UHFFFAOYSA-N 0.000 description 1
- LZTYIVIEZYEWLJ-UHFFFAOYSA-N COc(cc1-c(ccc(CN)c2)c2C2=CCOCC2)ccc1N Chemical compound COc(cc1-c(ccc(CN)c2)c2C2=CCOCC2)ccc1N LZTYIVIEZYEWLJ-UHFFFAOYSA-N 0.000 description 1
- JINBNAXJQKQDBQ-UHFFFAOYSA-N COc(cc1-c(ccc(COc2cccc(C(CC(O)=O)=C)c2)c2)c2OC2OCCCC2)ccc1F Chemical compound COc(cc1-c(ccc(COc2cccc(C(CC(O)=O)=C)c2)c2)c2OC2OCCCC2)ccc1F JINBNAXJQKQDBQ-UHFFFAOYSA-N 0.000 description 1
- CBOBCJSLITXAFU-UHFFFAOYSA-N COc(cc1-c2c(C(CC=C)(CC=C)O)cc(CO)cc2)ccc1F Chemical compound COc(cc1-c2c(C(CC=C)(CC=C)O)cc(CO)cc2)ccc1F CBOBCJSLITXAFU-UHFFFAOYSA-N 0.000 description 1
- DHADXDMPEUWEAS-UHFFFAOYSA-N COc1ccc(B(O)O)cn1 Chemical compound COc1ccc(B(O)O)cn1 DHADXDMPEUWEAS-UHFFFAOYSA-N 0.000 description 1
- YPNJEBYQBOLQMQ-SFHVURJKSA-N C[C@@H](CC(O)=O)c1cccc(OCc(cc2C(C)(C)C)ccc2-c2cc(OC)ccc2F)c1 Chemical compound C[C@@H](CC(O)=O)c1cccc(OCc(cc2C(C)(C)C)ccc2-c2cc(OC)ccc2F)c1 YPNJEBYQBOLQMQ-SFHVURJKSA-N 0.000 description 1
- MDNBIGLCJFGLER-JGZNSJETSA-N C[C@@H](CC(OC)=O)c1cc(OCc(cc2)cc(OC3OCCCC3)c2-c2cc(OC)ccc2F)ccc1 Chemical compound C[C@@H](CC(OC)=O)c1cc(OCc(cc2)cc(OC3OCCCC3)c2-c2cc(OC)ccc2F)ccc1 MDNBIGLCJFGLER-JGZNSJETSA-N 0.000 description 1
- AGIYTWHTBQBIPH-HOTGVXAUSA-N C[C@@H]1N(Cc(cc(CCl)cc2)c2-c(cc(cc2)OC)c2F)[C@@H](C)CCC1 Chemical compound C[C@@H]1N(Cc(cc(CCl)cc2)c2-c(cc(cc2)OC)c2F)[C@@H](C)CCC1 AGIYTWHTBQBIPH-HOTGVXAUSA-N 0.000 description 1
- JMILEXCUSYARCK-COBFLCELSA-N C[C@H](CC(O)=O)c1cc(OCc(cc2)cc(OC3OCCCC3)c2-c2cc(OC)ccc2F)ccc1 Chemical compound C[C@H](CC(O)=O)c1cc(OCc(cc2)cc(OC3OCCCC3)c2-c2cc(OC)ccc2F)ccc1 JMILEXCUSYARCK-COBFLCELSA-N 0.000 description 1
- MDNBIGLCJFGLER-UEWHNOOISA-N C[C@H](CC(OC)=O)c1cc(OCc(cc2)cc(OC3OCCCC3)c2-c2cc(OC)ccc2F)ccc1 Chemical compound C[C@H](CC(OC)=O)c1cc(OCc(cc2)cc(OC3OCCCC3)c2-c2cc(OC)ccc2F)ccc1 MDNBIGLCJFGLER-UEWHNOOISA-N 0.000 description 1
- YAGQTKVZMWEMLI-MRVPVSSYSA-N C[C@H](CC(OC)=O)c1cccc(O)c1 Chemical compound C[C@H](CC(OC)=O)c1cccc(O)c1 YAGQTKVZMWEMLI-MRVPVSSYSA-N 0.000 description 1
- ZTHRBJCNTAYZRE-SSDOTTSWSA-N C[C@H](Cc1cc(O)ccc1)C(O)=O Chemical compound C[C@H](Cc1cc(O)ccc1)C(O)=O ZTHRBJCNTAYZRE-SSDOTTSWSA-N 0.000 description 1
- AGIYTWHTBQBIPH-IYBDPMFKSA-N C[C@H]1N(Cc(cc(CCl)cc2)c2-c2cc(OC)ccc2F)[C@@H](C)CCC1 Chemical compound C[C@H]1N(Cc(cc(CCl)cc2)c2-c2cc(OC)ccc2F)[C@@H](C)CCC1 AGIYTWHTBQBIPH-IYBDPMFKSA-N 0.000 description 1
- OKDGVHWVIUMVLB-QNLPTKCRSA-N C[C@H]1N(Cc(cc(COc2cc([C@@H](CC(OC)=O)C3CC3)ccc2)cc2)c2-c2cc(OC)ccc2F)C(C)=CCC1 Chemical compound C[C@H]1N(Cc(cc(COc2cc([C@@H](CC(OC)=O)C3CC3)ccc2)cc2)c2-c2cc(OC)ccc2F)C(C)=CCC1 OKDGVHWVIUMVLB-QNLPTKCRSA-N 0.000 description 1
- PBMZTNXVKXURFJ-CYBMUJFWSA-N Cc1cccc([C@H](CC(O)=O)C2CCC2)c1 Chemical compound Cc1cccc([C@H](CC(O)=O)C2CCC2)c1 PBMZTNXVKXURFJ-CYBMUJFWSA-N 0.000 description 1
- NWBDGKNKAFGQQL-UHFFFAOYSA-N FC(Oc1cc(Br)ccc1)F Chemical compound FC(Oc1cc(Br)ccc1)F NWBDGKNKAFGQQL-UHFFFAOYSA-N 0.000 description 1
- JAICGBJIBWDEIZ-UHFFFAOYSA-N O=Cc1cccc(OCc2ccccc2)c1 Chemical compound O=Cc1cccc(OCc2ccccc2)c1 JAICGBJIBWDEIZ-UHFFFAOYSA-N 0.000 description 1
- QXCAHEXKUMUTRF-UHFFFAOYSA-N O=S(C(F)(F)F)(OC1=CCOCC1)=O Chemical compound O=S(C(F)(F)F)(OC1=CCOCC1)=O QXCAHEXKUMUTRF-UHFFFAOYSA-N 0.000 description 1
- QCSLIRFWJPOENV-UHFFFAOYSA-N OB(c(cccc1)c1F)O Chemical compound OB(c(cccc1)c1F)O QCSLIRFWJPOENV-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/62—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
- C07C217/62—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/16—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C317/22—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/10—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C323/18—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
- C07C323/19—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton with singly-bound oxygen atoms bound to acyclic carbon atoms of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
- C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
- C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/72—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings and other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/10—Systems containing only non-condensed rings with a five-membered ring the ring being unsaturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/18—Systems containing only non-condensed rings with a ring being at least seven-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
- C07C2602/42—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing seven carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/58—Ring systems containing bridged rings containing three rings
- C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
- C07C2603/74—Adamantanes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Emergency Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Nutrition Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Ophthalmology & Optometry (AREA)
- Child & Adolescent Psychology (AREA)
- Gynecology & Obstetrics (AREA)
- Vascular Medicine (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrane Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Furan Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US99878607P | 2007-10-10 | 2007-10-10 | |
| US60/998786 | 2007-10-10 | ||
| US6872408P | 2008-03-06 | 2008-03-06 | |
| US61/068724 | 2008-03-06 | ||
| PCT/US2008/011422 WO2009048527A1 (en) | 2007-10-10 | 2008-10-03 | Substituted biphenyl gpr40 modulators |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102083783A true CN102083783A (zh) | 2011-06-01 |
Family
ID=40338063
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2008801199462A Pending CN102083783A (zh) | 2007-10-10 | 2008-10-03 | 取代的联苯gpr40调节剂 |
Country Status (19)
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104059039A (zh) * | 2013-03-22 | 2014-09-24 | 正大天晴药业集团股份有限公司 | 具有gpr40受体功能调节作用的稠环化合物 |
| CN105189439A (zh) * | 2013-03-14 | 2015-12-23 | 百时美施贵宝公司 | 二环[2.2.1]酸gpr120调节剂 |
| CN110719903A (zh) * | 2017-03-31 | 2020-01-21 | 武田药品工业株式会社 | 芳族环化合物 |
| WO2022028317A1 (en) * | 2020-08-05 | 2022-02-10 | Rezubio Pharmaceuticals Co., Ltd | Antidiabetic compounds and compositions |
| WO2023134712A1 (en) * | 2022-01-14 | 2023-07-20 | Rezubio Pharmaceuticals Co., Ltd | Antidiabetic compounds and compositions |
| CN117603029A (zh) * | 2023-11-21 | 2024-02-27 | 江苏禾本生化有限公司 | 一种戊菌唑关键中间体的合成方法 |
| WO2024164915A1 (en) * | 2023-02-07 | 2024-08-15 | Rezubio Pharmaceuticals Co., Ltd | Conjugate compounds and compositions |
| WO2024188313A1 (zh) * | 2023-03-14 | 2024-09-19 | 凯思凯迪(上海)医药科技有限公司 | 苯并杂环类化合物、其制备方法和其应用 |
Families Citing this family (54)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101396696B1 (ko) | 2007-10-10 | 2014-05-16 | 노파르티스 아게 | 스피로피롤리딘, 및 hcv 및 hiv 감염에 대한 그의 용도 |
| WO2009111056A1 (en) * | 2008-03-06 | 2009-09-11 | Amgen Inc. | Conformationally constrained carboxylic acid derivatives useful for treating metabolic disorders |
| AU2009303475B2 (en) * | 2008-10-15 | 2012-09-13 | Amgen Inc. | Spirocyclic GPR40 modulators |
| AR074760A1 (es) | 2008-12-18 | 2011-02-09 | Metabolex Inc | Agonistas del receptor gpr120 y usos de los mismos en medicamentos para el tratamiento de diabetes y el sindrome metabolico. |
| PH12012501456A1 (en) | 2009-12-25 | 2012-10-29 | Mochida Pharm Co Ltd | Novel 3-hydroxy -5- arylisothiazole derivative |
| WO2011107494A1 (de) | 2010-03-03 | 2011-09-09 | Sanofi | Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung |
| US8299117B2 (en) | 2010-06-16 | 2012-10-30 | Metabolex Inc. | GPR120 receptor agonists and uses thereof |
| ES2526124T3 (es) * | 2010-06-16 | 2015-01-07 | Cymabay Therapeutics, Inc. | Agonistas del receptor GPR120 y sus usos |
| US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
| TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
| TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
| TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
| AU2011313191A1 (en) | 2010-10-08 | 2013-05-02 | Mochida Pharmaceutical Co., Ltd. | Cyclic amide derivative |
| CN102617501A (zh) * | 2011-01-31 | 2012-08-01 | 中国科学院上海药物研究所 | 取代正戊酰胺类化合物、其制备方法及用途 |
| AR085990A1 (es) | 2011-04-27 | 2013-11-13 | Mochida Pharm Co Ltd | Derivados de 1-oxido de 3-hidroxiisotiazol utiles en el tratamiento de la diabetes y composiciones farmaceuticas que los contienen |
| JPWO2012147516A1 (ja) | 2011-04-28 | 2014-07-28 | 持田製薬株式会社 | 環状アミド誘導体 |
| WO2013037390A1 (en) | 2011-09-12 | 2013-03-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| EP2760862B1 (en) | 2011-09-27 | 2015-10-21 | Sanofi | 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
| WO2013122029A1 (ja) | 2012-02-13 | 2013-08-22 | 武田薬品工業株式会社 | 芳香環化合物 |
| EP2816023A4 (en) | 2012-02-13 | 2015-09-09 | Takeda Pharmaceutical | AROMATIC RING CONNECTION |
| TW201341356A (zh) * | 2012-02-28 | 2013-10-16 | 皮拉馬爾企業有限公司 | 作為gpr促效劑之苯基烷酸衍生物 |
| AU2013290100A1 (en) | 2012-07-11 | 2015-01-29 | Elcelyx Therapeutics, Inc. | Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk |
| US20140045746A1 (en) | 2012-08-02 | 2014-02-13 | Merck Sharp & Dohme Corp. | Antidiabetic tricyclic compounds |
| CN105142621A (zh) | 2012-10-24 | 2015-12-09 | 国家健康科学研究所 | 用于预防或治疗糖尿病和促进β-细胞存活的TPL2激酶抑制剂 |
| KR101942752B1 (ko) * | 2012-11-05 | 2019-01-28 | 주식회사 엘지화학 | Gpr120 효능제로서의 티오아릴 유도체 |
| UY35143A (es) | 2012-11-16 | 2014-05-30 | Bristol Myers Squibb Co | Derivados de dihidropirazol como moduladores del receptor acoplado a la proteína gpr40 g |
| JP2016516004A (ja) | 2013-02-22 | 2016-06-02 | メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. | 抗糖尿病二環式化合物 |
| KR101569522B1 (ko) * | 2013-04-18 | 2015-11-17 | 현대약품 주식회사 | 신규한 3-(4-(벤질옥시)페닐)헥스-4-이노익 산 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 대사성 질환의 예방 또는 치료용 약학적 조성물 |
| ES2672992T3 (es) * | 2013-08-09 | 2018-06-19 | Takeda Pharmaceutical Company Limited | Compuesto aromático |
| WO2015051496A1 (en) | 2013-10-08 | 2015-04-16 | Merck Sharp & Dohme Corp. | Antidiabetic tricyclic compounds |
| CN105722841A (zh) | 2013-11-14 | 2016-06-29 | 卡迪拉保健有限公司 | 新型杂环化合物 |
| US10519115B2 (en) | 2013-11-15 | 2019-12-31 | Merck Sharp & Dohme Corp. | Antidiabetic tricyclic compounds |
| WO2015084692A1 (en) | 2013-12-04 | 2015-06-11 | Merck Sharp & Dohme Corp. | Antidiabetic bicyclic compounds |
| WO2015089809A1 (en) | 2013-12-19 | 2015-06-25 | Merck Sharp & Dohme Corp. | Antidiabetic substituted heteroaryl compounds |
| US10059667B2 (en) | 2014-02-06 | 2018-08-28 | Merck Sharp & Dohme Corp. | Antidiabetic compounds |
| WO2015176267A1 (en) | 2014-05-22 | 2015-11-26 | Merck Sharp & Dohme Corp. | Antidiabetic tricyclic compounds |
| WO2016022448A1 (en) | 2014-08-08 | 2016-02-11 | Merck Sharp & Dohme Corp. | Antidiabetic bicyclic compounds |
| WO2016019587A1 (en) | 2014-08-08 | 2016-02-11 | Merck Sharp & Dohme Corp. | [7, 6]-fused bicyclic antidiabetic compounds |
| WO2016022742A1 (en) | 2014-08-08 | 2016-02-11 | Merck Sharp & Dohme Corp. | Antidiabetic bicyclic compounds |
| US10100042B2 (en) | 2014-08-08 | 2018-10-16 | Merck Sharp & Dohme Corp. | [5,6]—fused bicyclic antidiabetic compounds |
| EP3273981B1 (en) | 2015-03-24 | 2020-04-29 | INSERM - Institut National de la Santé et de la Recherche Médicale | Method and pharmaceutical composition for use in the treatment of diabetes |
| EP3436003B1 (en) | 2016-03-29 | 2023-08-23 | Merck Sharp & Dohme LLC | Antidiabetic bicyclic compounds |
| WO2018106518A1 (en) | 2016-12-06 | 2018-06-14 | Merck Sharp & Dohme Corp. | Antidiabetic heterocyclic compounds |
| WO2018118670A1 (en) | 2016-12-20 | 2018-06-28 | Merck Sharp & Dohme Corp. | Antidiabetic spirochroman compounds |
| AR111199A1 (es) | 2017-03-31 | 2019-06-12 | Takeda Pharmaceuticals Co | Compuesto aromático agonista de gpr40 |
| BR102018007822A2 (pt) | 2017-04-20 | 2018-11-06 | Gilead Sciences, Inc. | composto, métodos para inibir pd-1, pd-l1 e/ou interação de pd-1/pd-l1 e para tratamento de câncer, composição farmacêutica, e, kit para tratamento de ou prevenção de câncer ou uma doença ou condição |
| US11225471B2 (en) | 2017-11-16 | 2022-01-18 | Merck Sharp & Dohme Corp. | Antidiabetic bicyclic compounds |
| WO2019160882A1 (en) | 2018-02-13 | 2019-08-22 | Gilead Sciences, Inc. | Pd-1/pd-l1 inhibitors |
| KR102591947B1 (ko) | 2018-04-19 | 2023-10-25 | 길리애드 사이언시즈, 인코포레이티드 | Pd-1/pd-l1 억제제 |
| PE20210642A1 (es) | 2018-07-13 | 2021-03-23 | Gilead Sciences Inc | Inhibidores de pd-1/pd-l1 |
| US11236085B2 (en) | 2018-10-24 | 2022-02-01 | Gilead Sciences, Inc. | PD-1/PD-L1 inhibitors |
| US20220152164A1 (en) * | 2019-03-22 | 2022-05-19 | Kallyope, Inc. | Gpcr combination therapies |
| MX2022010548A (es) | 2020-02-28 | 2022-09-23 | Kallyope Inc | Agonistas de gpr40. |
| KR20250079173A (ko) | 2022-10-03 | 2025-06-04 | 고리츠다이가쿠호진 요코하마시리츠다이가쿠 | 이환성 구조를 갖는 이미다조피리딘 유도체 |
Family Cites Families (73)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE305216B (cg-RX-API-DMAC7.html) | 1965-09-17 | 1968-10-21 | Astra Apotekarnes Kem Fab | |
| FR2359135A1 (fr) | 1976-07-22 | 1978-02-17 | Hexachimie | Nouvelles phenoxyhydroxypropylamines, procede pour les preparer et leur application en therapeutique |
| US4760089A (en) | 1985-09-09 | 1988-07-26 | Smithkline Beckman Corporation | Irreversible dopamine-β-hydroxylase inhibitors |
| PT85081A (en) | 1986-06-19 | 1987-07-01 | Smithkline Beckman Corp | Irreversible dopamine-beta-hydroxylase inhibitors |
| GB8917069D0 (en) | 1989-07-26 | 1989-09-13 | Merck Sharp & Dohme | Therapeutic agents |
| DE4019307A1 (de) | 1990-06-16 | 1991-12-19 | Bayer Ag | 2-methoximinocarbonsaeureester |
| WO1993023040A1 (en) | 1992-05-20 | 1993-11-25 | Merck & Co., Inc. | 17-ethers and thioethers of 4-aza-steroids |
| ATE198601T1 (de) | 1992-05-20 | 2001-01-15 | Merck & Co Inc | Ester derivate von 4-aza-steroiden |
| DE4241632A1 (de) | 1992-12-10 | 1994-06-16 | Thomae Gmbh Dr K | Carbonsäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
| JP3894949B2 (ja) | 1993-06-30 | 2007-03-22 | ザ、ウェルカム、ファンデーション、リミテッド | 抗アテローム性動脈硬化症ジアリール化合物 |
| US5463063A (en) | 1993-07-02 | 1995-10-31 | Celgene Corporation | Ring closure of N-phthaloylglutamines |
| AU6490396A (en) | 1995-07-14 | 1997-02-18 | Smithkline Beecham Corporation | Substituted-pent-4-ynoic acids |
| US5795900A (en) | 1995-10-03 | 1998-08-18 | Abbott Laboratories | Symmetrical bis-heteroaryl-methoxy-phenylalkyl carboxylates as inhibitors of leukotriene biosynthesis |
| JPH10316641A (ja) | 1997-03-14 | 1998-12-02 | Sankyo Co Ltd | カルボン酸誘導体 |
| AU8750298A (en) | 1997-08-28 | 1999-03-22 | Ono Pharmaceutical Co. Ltd. | Peroxisome proliferator-activated receptor controllers |
| US6645939B1 (en) | 1997-11-24 | 2003-11-11 | Merck & Co., Inc. | Substituted β-alanine derivatives as cell adhesion inhibitors |
| DE69941777D1 (de) * | 1998-03-10 | 2010-01-21 | Ono Pharmaceutical Co | Carbonsäurederivate und medikamente die diese als aktiven wirkstoff enthalten |
| DE19941567A1 (de) | 1998-09-05 | 2000-04-20 | Merck Patent Gmbh | Neue flüssigkristalline Verbindungen |
| AU3958200A (en) | 1999-04-20 | 2000-11-02 | Novo Nordisk A/S | New compounds, their preparation and use |
| AU4591800A (en) | 1999-05-05 | 2000-11-21 | Aventis Pharma Limited | Ureas as cell adhesion modulators |
| GB9914977D0 (en) | 1999-06-25 | 1999-08-25 | Glaxo Group Ltd | Chemical compounds |
| GB9927056D0 (en) | 1999-11-17 | 2000-01-12 | Karobio Ab | Thyroid receptor antagonists for the treatment of cardiac and metabolic disorders |
| WO2001036351A2 (en) | 1999-11-19 | 2001-05-25 | Corvas International, Inc. | Plasminogen activator inhibitor antagonists related applications |
| JP2001242165A (ja) | 2000-02-25 | 2001-09-07 | Dai Ichi Seiyaku Co Ltd | 採血用試薬 |
| JP2002003368A (ja) | 2000-06-23 | 2002-01-09 | Saitama Daiichi Seiyaku Kk | 経皮吸収又は経粘膜吸収用の製剤 |
| GB0031107D0 (en) | 2000-12-20 | 2001-01-31 | Glaxo Group Ltd | Chemical compounds |
| US6906046B2 (en) | 2000-12-22 | 2005-06-14 | Celltech R & D Inc. | Pharmaceutical uses and synthesis of benzobicyclooctanes |
| GB0031527D0 (en) | 2000-12-22 | 2001-02-07 | Smithkline Beecham Plc | New use |
| ATE433964T1 (de) | 2000-12-28 | 2009-07-15 | Takeda Pharmaceutical | Alkansäurederivate, verfahren zu deren herstellung und deren verwendung |
| TWI311133B (en) | 2001-04-20 | 2009-06-21 | Eisai R&D Man Co Ltd | Carboxylic acid derivativeand the salt thereof |
| DE60216094T2 (de) | 2001-06-07 | 2007-06-06 | Eli Lilly And Co., Indianapolis | Modulatoren der peroxisom-proliferator-aktivierten rezeptoren (ppar) |
| JP4705756B2 (ja) | 2002-02-07 | 2011-06-22 | 仁 遠藤 | 芳香族アミノ酸誘導体及び医薬組成物 |
| US7214495B2 (en) | 2002-02-14 | 2007-05-08 | Takeda Pharmaceutical Company Limited | Screening method |
| US20030207924A1 (en) | 2002-03-07 | 2003-11-06 | Xue-Min Cheng | Compounds that modulate PPAR activity and methods of preparation |
| US6875780B2 (en) | 2002-04-05 | 2005-04-05 | Warner-Lambert Company | Compounds that modulate PPAR activity and methods for their preparation |
| WO2003099793A1 (en) | 2002-05-24 | 2003-12-04 | Takeda Pharmaceutical Company Limited | 1,2-azole derivatives with hypoglycemic and hypolipidemic activity |
| GB0214149D0 (en) | 2002-06-19 | 2002-07-31 | Glaxo Group Ltd | Chemical compounds |
| US7553867B2 (en) | 2002-09-06 | 2009-06-30 | Takeda Pharmaceutical Company Limited | Furan or thiophene derivative and medicinal use thereof |
| JP4594611B2 (ja) * | 2002-11-08 | 2010-12-08 | 武田薬品工業株式会社 | 受容体機能調節剤 |
| AU2003277576A1 (en) | 2002-11-08 | 2004-06-07 | Takeda Pharmaceutical Company Limited | Receptor function controlling agent |
| US20060258683A1 (en) | 2003-04-07 | 2006-11-16 | Liu Kevin | Para-sulfonyl substituted phenyl compounds as modulators of ppars |
| US7820837B2 (en) | 2003-05-30 | 2010-10-26 | Takeda Pharmaceutical Company Limited | Condensed ring compound |
| WO2005051890A1 (en) | 2003-11-19 | 2005-06-09 | Smithkline Beecham Corporation | Aminophenylcyclopropyl carboxylic acids and derivatives as agonists to gpr40 |
| US7605171B2 (en) | 2003-12-17 | 2009-10-20 | Merck & Co., Inc. | (3,4-disubstituted)propanoic carboxylates as S1P (Edg) receptor agonists |
| US7456218B2 (en) | 2003-12-25 | 2008-11-25 | Takeda Pharmaceutical Company Limited | 3-(4-benzyloxyphenyl) propanoic acid derivatives |
| JP4074616B2 (ja) * | 2003-12-25 | 2008-04-09 | 武田薬品工業株式会社 | 3−(4−ベンジルオキシフェニル)プロパン酸誘導体 |
| WO2005063725A1 (ja) | 2003-12-26 | 2005-07-14 | Takeda Pharmaceutical Company Limited | フェニルプロパン酸誘導体 |
| US7326732B2 (en) | 2004-02-12 | 2008-02-05 | Pharmagene Laboratories Limited | EP2 receptor agonists |
| EP1737809B1 (en) | 2004-02-27 | 2013-09-18 | Amgen, Inc | Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders |
| WO2005087710A1 (ja) | 2004-03-15 | 2005-09-22 | Takeda Pharmaceutical Company Limited | アミノフェニルプロパン酸誘導体 |
| JP4859665B2 (ja) * | 2004-03-30 | 2012-01-25 | 武田薬品工業株式会社 | アルコキシフェニルプロパン酸誘導体 |
| US7989457B2 (en) * | 2004-05-28 | 2011-08-02 | Eli Lilly And Company | Glucagon receptor antagonists, preparation and therapeutic uses |
| JP2007269630A (ja) | 2004-06-23 | 2007-10-18 | Toudai Tlo Ltd | インスリン分泌促進剤 |
| US20060003344A1 (en) | 2004-06-30 | 2006-01-05 | Pfizer Inc. | Methods related to a single nucleotide polymorphism of the G protein coupled receptor, GPR40 |
| JP2007284350A (ja) | 2004-07-27 | 2007-11-01 | Takeda Chem Ind Ltd | 糖尿病治療剤 |
| CN101106991A (zh) | 2005-01-28 | 2008-01-16 | 默克公司 | 抗糖尿病的双环化合物 |
| JP2008528628A (ja) | 2005-01-31 | 2008-07-31 | メルク エンド カムパニー インコーポレーテッド | 抗糖尿病性二環式化合物 |
| US7465804B2 (en) | 2005-05-20 | 2008-12-16 | Amgen Inc. | Compounds, pharmaceutical compositions and methods for their use in treating metabolic disorders |
| WO2007008541A2 (en) | 2005-07-08 | 2007-01-18 | Kalypsys, Inc. | Cellular cholesterol absorption modifiers |
| EP1916234B1 (en) | 2005-07-29 | 2014-11-12 | Takeda Pharmaceutical Company Limited | Cyclopropanecarboxylic acid compound |
| US7582803B2 (en) | 2005-09-14 | 2009-09-01 | Amgen Inc. | Conformationally constrained 3-(4-hydroxy-phenyl)-substituted-propanoic acids useful for treating metabolic disorders |
| WO2007049050A2 (en) | 2005-10-27 | 2007-05-03 | Heptahelix Ab | Modulators of gpr40 for the treatment of diabetes |
| AU2007225208A1 (en) | 2006-03-14 | 2007-09-20 | Amgen Inc. | Bicyclic carboxylic acid derivatives useful for treating metabolic disorders |
| TW200815377A (en) | 2006-04-24 | 2008-04-01 | Astellas Pharma Inc | Oxadiazolidinedione compound |
| DE102006021874B4 (de) | 2006-05-11 | 2008-03-27 | Sanofi-Aventis | 4,5-Diphenyl-pyrimidinyl-amino substituierte Carbonsäuren, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| DE102006021878A1 (de) | 2006-05-11 | 2007-11-15 | Sanofi-Aventis | Phenylamino-benzoxazol substituierte Carbonsäuren, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| DE102006021872B4 (de) | 2006-05-11 | 2008-04-17 | Sanofi-Aventis | 4,5-Diphenyl-pyrimidinyl-oxy oder -mercapto substituierte Carbonsäuren, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| AU2007254325B2 (en) | 2006-05-15 | 2012-05-10 | Merck Sharp & Dohme Corp. | Antidiabetic bicyclic compounds |
| AU2007265966B2 (en) | 2006-06-27 | 2012-05-17 | Takeda Pharmaceutical Company Limited | Fused cyclic compounds |
| EP2061760A1 (en) | 2006-09-07 | 2009-05-27 | Amgen, Inc | Benzo-fused compounds for use in treating metabolic disorders |
| CA2662305C (en) | 2006-09-07 | 2012-04-17 | Amgen Inc. | Heterocyclic gpr40 modulators |
| AU2007314405A1 (en) | 2006-10-31 | 2008-05-08 | Merck & Co., Inc. | Antidiabetic bicyclic compounds |
| ES2446419T3 (es) | 2007-04-16 | 2014-03-07 | Amgen, Inc | Moduladores de GPR40 de ácidos bifenilfenoxi, tiofenil y aminofenilpropanoico sustituidos |
-
2008
- 2008-10-03 JP JP2010528867A patent/JP5591706B2/ja not_active Expired - Fee Related
- 2008-10-03 WO PCT/US2008/011422 patent/WO2009048527A1/en not_active Ceased
- 2008-10-03 CA CA2702047A patent/CA2702047C/en not_active Expired - Fee Related
- 2008-10-03 BR BRPI0818253-1A patent/BRPI0818253A2/pt not_active Application Discontinuation
- 2008-10-03 KR KR1020107010209A patent/KR20100090249A/ko not_active Withdrawn
- 2008-10-03 CN CN2008801199462A patent/CN102083783A/zh active Pending
- 2008-10-03 AU AU2008311355A patent/AU2008311355B2/en not_active Ceased
- 2008-10-03 MX MX2010003876A patent/MX2010003876A/es active IP Right Grant
- 2008-10-03 EP EP08837085A patent/EP2205548A1/en not_active Withdrawn
- 2008-10-03 US US12/287,036 patent/US8030354B2/en active Active
- 2008-10-09 PE PE2008001746A patent/PE20091222A1/es not_active Application Discontinuation
- 2008-10-09 CL CL2008002997A patent/CL2008002997A1/es unknown
- 2008-10-09 AR ARP080104409A patent/AR068840A1/es not_active Application Discontinuation
- 2008-10-09 TW TW097139006A patent/TW200927091A/zh unknown
-
2010
- 2010-03-21 IL IL204635A patent/IL204635A0/en unknown
- 2010-03-22 TN TNP2010000125A patent/TN2010000125A1/fr unknown
- 2010-05-06 CO CO10054070A patent/CO6270312A2/es not_active Application Discontinuation
- 2010-05-10 MA MA32826A patent/MA31841B1/fr unknown
- 2010-05-10 CR CR11420A patent/CR11420A/es not_active Application Discontinuation
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105189439A (zh) * | 2013-03-14 | 2015-12-23 | 百时美施贵宝公司 | 二环[2.2.1]酸gpr120调节剂 |
| CN105189439B (zh) * | 2013-03-14 | 2017-12-29 | 百时美施贵宝公司 | 二环[2.2.1]酸gpr120调节剂 |
| CN104059039A (zh) * | 2013-03-22 | 2014-09-24 | 正大天晴药业集团股份有限公司 | 具有gpr40受体功能调节作用的稠环化合物 |
| CN104059039B (zh) * | 2013-03-22 | 2017-03-15 | 正大天晴药业集团股份有限公司 | 具有gpr40受体功能调节作用的稠环化合物 |
| CN110719903A (zh) * | 2017-03-31 | 2020-01-21 | 武田药品工业株式会社 | 芳族环化合物 |
| WO2022028317A1 (en) * | 2020-08-05 | 2022-02-10 | Rezubio Pharmaceuticals Co., Ltd | Antidiabetic compounds and compositions |
| CN116472273A (zh) * | 2020-08-05 | 2023-07-21 | 宁康瑞珠生物制药(珠海)有限公司 | 抗糖尿病化合物和组合物 |
| WO2023134712A1 (en) * | 2022-01-14 | 2023-07-20 | Rezubio Pharmaceuticals Co., Ltd | Antidiabetic compounds and compositions |
| WO2024164915A1 (en) * | 2023-02-07 | 2024-08-15 | Rezubio Pharmaceuticals Co., Ltd | Conjugate compounds and compositions |
| WO2024188313A1 (zh) * | 2023-03-14 | 2024-09-19 | 凯思凯迪(上海)医药科技有限公司 | 苯并杂环类化合物、其制备方法和其应用 |
| CN117603029A (zh) * | 2023-11-21 | 2024-02-27 | 江苏禾本生化有限公司 | 一种戊菌唑关键中间体的合成方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2009048527A1 (en) | 2009-04-16 |
| IL204635A0 (en) | 2010-11-30 |
| US20090137561A1 (en) | 2009-05-28 |
| TW200927091A (en) | 2009-07-01 |
| MX2010003876A (es) | 2010-12-02 |
| TN2010000125A1 (en) | 2011-09-26 |
| MA31841B1 (fr) | 2010-11-01 |
| AU2008311355B2 (en) | 2012-01-19 |
| CR11420A (es) | 2010-08-12 |
| JP5591706B2 (ja) | 2014-09-17 |
| BRPI0818253A2 (pt) | 2015-04-07 |
| KR20100090249A (ko) | 2010-08-13 |
| CA2702047C (en) | 2012-04-17 |
| PE20091222A1 (es) | 2009-09-14 |
| EP2205548A1 (en) | 2010-07-14 |
| AR068840A1 (es) | 2009-12-09 |
| JP2011500562A (ja) | 2011-01-06 |
| CA2702047A1 (en) | 2009-04-16 |
| AU2008311355A1 (en) | 2009-04-16 |
| CL2008002997A1 (es) | 2009-10-09 |
| US8030354B2 (en) | 2011-10-04 |
| CO6270312A2 (es) | 2011-04-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5591706B2 (ja) | 置換ビフェニルgpr40調節因子 | |
| AU2009220163B2 (en) | Conformationally constrained carboxylic acid derivatives useful for treating metabolic disorders | |
| EP2358656B1 (en) | Spirocyclic gpr40 modulators | |
| JP2021531325A (ja) | 甲状腺ホルモン受容体アゴニスト及びその用途 | |
| KR101021828B1 (ko) | 2 이상의 치환기를 갖는 벤젠 화합물 | |
| CN105189516B (zh) | 氧杂二环[2.2.2]酸gpr120调节剂 | |
| CN103415507B (zh) | 作为gpbar1激动剂的3-氨基-吡啶类 | |
| EP3034501A1 (en) | Hydroxy containing FXR (NR1H4) modulating compounds | |
| CN109996797B (zh) | 作为乳酸脱氢酶的抑制剂的1h-吡唑-1-基-噻唑及其使用方法 | |
| JP2010524932A (ja) | 置換ビフェニルフェノキシ−、チオフェニル−及びアミノフェニルプロパン酸gpr40調節物質 | |
| JPWO2003064369A1 (ja) | 新規な甲状腺ホルモン受容体リガンド、それを含有する医薬組成物、およびそれらの用途 | |
| TW201629024A (zh) | 作為lpxc抑制劑之異唑異羥肟酸化合物 | |
| WO2013122028A1 (ja) | 芳香環化合物 | |
| CN115916740A (zh) | 拟甲状腺素药 | |
| ZA200600819B (en) | Cycloalkylidene compounds as modulators of estrogen receptor | |
| TW201431841A (zh) | 作爲gpr120促效劑之硫基芳基衍生物 | |
| KR20030030381A (ko) | 사이클로옥시게나제-2의 저해제로서 선택성이 뛰어난4'-메탄설포닐-비페닐 유도체 | |
| US4107329A (en) | Fluorinated compounds as therapeutics | |
| JP2005519951A (ja) | β3アドレナリン性受容体作動薬としてのアミノアルコール誘導体 | |
| HK1224676A (en) | Hydroxy containing fxr (nr1h4) modulating compounds | |
| HK1224676A1 (en) | Hydroxy containing fxr (nr1h4) modulating compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20110601 |